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Abstract 
 
Photoacoustic molecular imaging (PMI) is a non-ionizing imaging modality that can 
provide functional and metabolic information at clinically relevant penetration depth (~ 2 
cm) with submillimeter spatial resolution. This doctoral dissertation focuses on applying 
PMI to measure the activity of matrix metalloproteinase 2 (MMP-2), an enzymatic marker 
of cancer progression capable of altering the tumor microenvironment. Photoacoustic 
lifetime imaging (PALI) is used to probe the transient absorption of an activatable probe 
capable of changing its excited-state lifetime from short (1 – 10 ns) to long (1 – 10 µs) 
upon cleavage by MMP-2. Several models were developed to test the hypothesis of lifetime 
contrast between the inactive and active form of the probe. A series of peptide-based 
activatable photoacoustic probes of varying length and structure were synthesized. In order 
to enlighten the structure/function relationship and identify the optimal probe, we 
compared their dimerization and separation efficiency, activation rate, and photoacoustic 
lifetime signal strength with respect to a non-activatable control.  Our long-term goal is to 
implement this technique to image the activity of enzymes involved in pathological 
processes in clinical settings. To this end, we have developed a portable multimodal 
imaging system for the simultaneous visualization of ultrasound anatomical images and 
PALI enzymatic activity. Ultimately, this technique could be translated into an early-stage 
cancer diagnostic or prognostic tool, as well as for personalized treatment planning or 
continuous monitoring of treatment efficacy. 
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Preface 
This thesis describes the step-by-step development of the first activatable 
photoacoustic imaging probe for enzyme activity detection based on lifetime contrast. It 
comprises materials that have been published or soon-to-be submitted for publication to 
academic journals and includes contributions by multiple authors.  
Chapter 1: Introduction presents the clinical significance of this work for cancer 
diagnosis and treatment and the principles behind photoacoustic lifetime imaging. An 
example of photoacoustic lifetime imaging applied to tumor hypoxia mapping was adapted 
from In vivo photoacoustic lifetime imaging of tumor hypoxia in small animals by Q. Shao, 
E. Morgounova (Ippolito), C. Jiang, J. Choi, J. Bischof, and S. Ashkenazi in the Journal of 
Biomedical Optics 18(7) (2013) [53]. In this example, the animal work and data analysis 
were performed by Q. Shao. E. Ippolito provided support and input with experiment 
conception and manuscript revision. 
Chapter 2: A chemical model for MB dimerization describes the testing of the 
hypothesis of lifetime switching from high (1-10 µs) to low (1-10 ns) between methylene 
blue monomers and dimers. This work was published in Photoacoustic lifetime contrast 
between methylene blue monomers and self-quenched dimers as a model for dual-labeled 
activatable probes by E. Morgounova (Ippolito), Q. Shao, B. J. Hackel, D. D. Thomas, and 
S. Ashkenazi in the Journal of biomedical optics 18(5) (2013) [115]. Experiment 
conception and implementation, data analysis and manuscript writing were performed by 
E. Ippolito. S. Ashkenazi oversaw the project. Q. Shao, D. D. Thomas, and S. Ashkenazi 
provided input with experiment conception and reviewed the manuscript. 
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Chapter 3: Activatable probe design and evaluation presents the design, synthesis and 
evaluation of a series of activatable photoacoustic probe. This work is under review and 
will soon be submitted for publication as: Engineering a Lifetime-Based Activatable 
Photoacoustic Probe for Matrix Metalloproteinase 2 by E. M. Ippolito, S. M. Johnson, B. 
J. Hackel, M. Wilson, and S. Ashkenazi. It is partly adapted from Lifetime-based 
photoacoustic probe activation modeled by a dual methylene blue-lysine 
conjugate, Proceedings of SPIE, 89435F (2014), and In vitro characterization of a lifetime-
based activatable photoacoustic probe, Proceedings of SPIE, 93232J (2015), by the same 
authors. E. Ippolito conceived, performed and analyzed photoacoustic experiments, and 
conceived and analyzed absorption and kinetics experiments. S. Johnson performed 
conjugation and peptide synthesis, and conceived and performed kinetic experiments. Both 
E. Ippolito and S. Johnson performed absorption experiments. B. J. Hackel, M. Wilson, and 
S. Ashkenazi oversaw the project. E. Ippolito wrote the manuscript with support and input 
from all the authors. 
Chapter 4: Towards in vivo imaging presents unpublished work by E. Ippolito 
on the development of a multimodal system for combined US/PA/PALI imaging. S. 
Ashkenazi oversaw the project. 
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Chapter 1.  
Introduction 
 
1.1   CLINICAL SIGNIFICANCE 
1.1.1   Cancer incidence and approach to treatment 
Current estimates indicate that one of three Americans are or will be affected by 
cancer during their lifetime, and that the incidence of cancer rate has doubled in the past 
20 years [1]. Cancer is caused by an accumulation of genetic mutations affecting cellular 
regulatory pathways such as pro-angiogenic growth factors, tumor suppressor genes, and 
apoptotic regulators, among others [2]. The incidence of cancer has been correlated with 
both genetic and environmental factors – including family history, lifestyle, and exposure 
to carcinogenic agents [3]. Due to the genetic complexity and variability across different 
cancer types, it is nearly impossible to eliminate all cancers, nor is it currently possible to 
reprogram cancer cells to revert to their normal state [4]. For now, the one key to reduce 
cancer incidence and cancer-associated deaths consists in early, accurate diagnosis at a pre-
cancerous or treatable stage. In addition, personalized medicine, or the use of individual 
genomic, proteomic (e.g. enzymes) and metabolic (e.g. oxygen) information to guide 
treatment options, can improve tumor response and survival rates [5]. Finally, combining 
tumor localization and molecular characterization into a single step can deliver a powerful 
tool for early diagnosis and treatment monitoring.  
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1.1.2   Current and emerging methods for cancer diagnosis 
A first class of cancer diagnosis tools are screening tests that rely on blood samples, 
such as prostate-specific antigen (PSA) [6], or stool samples, such as multi-target stool 
DNA [7], to detect the presence of cancer biomarkers. In general, these tests have limited 
accuracy and require a confirmation of diagnosis using more invasive techniques. 
Several noninvasive imaging modalities are commonly used for the detection of 
tumor masses, such as computed tomography (CT), positron tomography (PET), magnetic 
resonance imaging (MRI), and ultrasound imaging (US) [8], sometimes in combination 
with contrast agents. Each technique possesses a spatial resolution/imaging depth trade-off 
(Figure 1.1) which defines their applicability to different types of tumor. They also present 
individual limitations in clinical settings, such as ionizing radiations for nuclear imaging, 
low sensitivity and high cost for MRI, and low organ/tumor contrast for ultrasound. 
Biopsy is currently the preferred method to confirm cancer diagnosis, as it provides 
information about histological type, classification, grade, and aggressiveness which may 
help determine the best treatment [9]. In some cases, especially for tumors located in deep-
seated organs like the prostate or the liver, ultrasound imaging may be used to guide the 
biopsy needle towards the tumor site. In other cases, such as polyp resection in the colon 
or the lungs, an endoscopic camera guides biopsy snare or forceps to the suspected area. 
Biopsy is always an invasive and painful procedure that may cause injury and spread of 
the disease [10]. Possible complications include spread of tumor cells, fever, infection, and 
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bleeding. Finally, very small tumors (< 1 mm) may be missed by ultrasounds or the biopsy 
needle may not be able to accurately target them or to obtain a decent sample size. 
 
Figure 1.1. Comparative trade-off between resolution and penetration depth for different imaging modalities. 
Abbreviations: MRI, magnetic resonance imaging; PET: positron emission tomography; OCT, optical 
coherence tomography. 
More recently, molecular imaging techniques have sought to simultaneously 
localize and characterize tumors non-invasively. By providing a map of metabolic or 
molecular expression or activity, they may help differentiate between a benign and a 
cancerous tumor, or between cancer and other pathologies (e.g. stomach cancer versus 
ulcer), therefore reducing the risk of unnecessary biopsies. Several molecular probes for 
  6 
clinically relevant modalities have been tested in animals and in humans, including targeted 
microbubbles for ultrasound [11], targeted magnetic nanoparticles for MRI [12] and 
radiolabeled probes for PET [13]. For cancer research, the most widely used technique is 
fluorescence imaging of near-infrared (NIR) probes [14-20]. Fluorescent probes can yield 
a highly specific contrast signal, but their imaging depth is limited to a few millimeters due 
to the diffuse nature of photon propagation in tissue, and their resolution deteriorates 
exponentially with increasing depth (Figure 1.1) [21]. Finally, photoacoustic (PAI) 
imaging, which combines the high contrast of optical molecular probes with the relatively 
high imaging depth and resolution of ultrasound, has been gaining grounds in preclinical 
studies and is recently being evaluated for breast cancer diagnosis [22]. 
1.1.1 Proteolytic markers for cancer diagnosis and treatment 
Proteases are enzymes that catalyze the hydrolytic cleavage of peptide bonds and 
participate in a variety of critical biological processes. In particular, proteases enable 
cancer cells to adapt to the topology of the primary and secondary tumor sites by altering 
the microenvironment [23]. Tumor-promoting proteases function as part of an extensive 
proteolytic network which interacts with cancer signaling pathways, simultaneously 
controlling and amplifying proteolytic activity during cancer progression [24, 25].  
 
Matrix metalloproteinases (MMPs) are a family of proteases that degrade proteins 
in tissue extracellular matrices (ECM) [26]. Such effects occur during embryogenesis and 
normal physiological tissue remodeling such as wound healing, but also during 
pathological processes such as tumor angiogenesis, invasion and metastasis [27-29], and 
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in inflammation related disease [30-32], arthritis [33, 34], and artherosclerosis [35, 36]. 
Their mode of action during cancer progression include promoting angiogenesis by 
recruiting vascular-associated pericytes, degrading ECM collagen to facilitate cell 
migration in the stroma, and degrading the basement membrane which allows cells to 
intravasate into the blood vessels [37]. MMPs inhibitors have been extensively studied as 
drug targets for cancer therapy [38], but those treatments have met with limited success so 
far, possibly due to the complexity of their signaling activities.  
Many different MMPs are typically overexpressed at any given point during 
tumorigenesis, however the overexpression of individual MMPs is differently regulated in 
time and among cell types [39]. In particular, type IV collagenases (MMP-2 and MMP-9) 
levels have been consistently reported by several studies to be up-regulated in biopsies and 
tissue specimens of prostate cancer [28, 39, 40]. We chose MMP-2 as our first target 
because it is among the best characterized proteases overexpressed by tumors. 
Developing a molecular probe that enable imaging of protease activity in living 
subjects with high resolution will have a contribution in the following areas: 1) basic 
research: to study the role of proteases in disease initiation and progression in animal 
models and to improve our understanding of underlying biological processes in cancer 
progression, 2) drug development: to visualize and quantify protease activity for the 
development of enzyme-mediated and enzyme-suppression drugs for cancer and other 
conditions caused by uncontrolled extra-cellular degradation, 3) clinical practice: to 
diagnose high expression levels for proteases and to monitor treatment efficacy in prostate 
cancer patients. 
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1.2.   PHOTOACOUSTIC IMAGING TECHNIQUES AND APPLICATIONS 
1.2.1   Photoacoustic Imaging (PAI) 
 PAI can surpass the imaging depth and resolution limitations of fluorescence 
imaging while simultaneously keeping the high contrast provided by the absorption 
differential between optical contrast agents and tissues [41]. It consists of laser pulse 
excitation followed by the detection of ultrasound waves generated by the thermoelastic 
expansion of absorbing molecules (Figure 1.2). Because the scattering of ultrasound waves 
is much weaker than that of light, the signal can propagate back from the generation site 
through several centimeters without significant attenuation. Backpropagation algorithms 
like those employed for ultrasound reconstruction are then used to reconstruct an image 
which is related to the optical energy distribution in the sample. 
 
Figure 1.2. Explanation of the photoacoustic effect.  
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The implementation of PAI in biomedical applications has rapidly evolved during 
the last decade. Imaging penetration depth of up to 5 cm has been demonstrated [42]. The 
resolution is determined by the bandwidth of the ultrasound transducer and is similar to 
that ultrasound pulse/echo imaging (0.2 to 0.02 mm) [43]. Contrast agents for PAI can be 
either endogenous – such as blood, lipids and melanin – or exogenous – such as dyes [44], 
metallic nanoparticles [45], carbon nanotubes [46] and even quantum dots [47]. PAI have 
been demonstrated in applications such as: imaging of blood vasculature [48], cancer tumor 
angiogenesis detection [49], lymph nodes imaging [49], and skin cancer imaging [50]. 
1.2.2   Photoacoustic pump-probe approach for excited-state lifetime probing 
In laser physics, the pump-probe technique has been used to probe the transient 
excited state of photoabsorbing molecules. An example of molecules with a long excited-
state lifetime are oxygen-sensitive dyes such as Methylene Blue (MB). MB has an 
absorption peak in the UV region (300 nm) and an even stronger peak in the NIR window 
(660 nm) where tissue absorption is minimal (Figure 1.3). When excited by a laser source, 
MB molecules transition from the ground state (S0) to a singlet excited state (S1) in a few 
femtoseconds, then spontaneously undergo intersystem-crossing (ISC) to a metastable 
triplet state (T1) (Figure 1.4). The triplet excited-state lifetime of MB was measured at 79.5 
µs in degassed water, but drops dramatically to 1.8 µs in air-saturated solution due to 
collisional, or dynamic, quenching with oxygen [51]. 
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Figure 1.3. Absorption spectra of MB chromophore for different concentrations. 
 
Figure 1.4. Energy diagram of MB chromophore. 
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Photoacoustic pump-probe measurement of the excited-state lifetime of MB 
happens in two steps. First, a laser pulse pumps MB to its excited state, then a second laser 
pulse is fired after the pump pulse to probe the triplet excited state by generating PA waves 
(Figure 1.5(a)). By repeating a sequence of pump-probe pulses with increasing time delays, 
it is possible to extract the excited-state lifetime by exponential fitting of the photoacoustic 
amplitude signal at each measurement point (Figure 1.6). Finally, the pump and probe laser 
wavelengths are chosen to produce the maximum of photoacoustic emission at 660 nm and 
840 nm, respectively (Figure 1.5(b-c)). 
 
Figure 1.6. (a) Photoacoustic amplitude signal of a plastic tube filled with MB dye at different pump-probe 
delay times. The two waveforms correspond to the back (x = 0.6 mm) and front (x = 2.2 mm) dye-plastic 
interfaces. (b) Photoacoustic excited-state lifetime as a function of position. The lifetime τ was calculated by 
applying an exponential fit to the PA amplitude data (PA = tPA*exp(-t/τ) + DC). Data points for which R2 < 
0.95 were excluded from the graph. (c) Transient photoacoustic amplitude (tPA) as a function of position. 
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Figure 1.5. (a) Pump-probe approach for photoacoustic imaging. tpp: pump-probe delay. (b) Photoacoustic 
response of MB chromophore for different pump wavelengths. (c) Transient photoacoustic response of MB 
chromophore for different probing wavelengths. 
1.2.3   Photoacoustic Lifetime Imaging (PALI) for oxygen mapping 
PALI implements the photoacoustic pump-probe approach to yield 2D images of 
the oxygen level in tissue. Excited-state lifetime (τ) and oxygen partial pressure (pO2) are 
related by the Stern-Volmer relationship:  
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Where τ0 = 79.5 µs,  the lifetime at pO2 = 0 mmHg, and kQ = 0.0036 µs-1.mmHg-1, the 
quenching rate constant [51].  
Our group has recently reported on the in vivo imaging of tumor hypoxia using 
PALI [52]. Tumors were induced in nude mice by subcutaneous injection of LNCaP cells 
into their hindlimbs. The tumors were grown for 3 - 5 weeks until they reached a diameter 
of 5 - 10 mm. The animals were then anesthetized and injected intratumorally with MB 
dissolved in physiological saline solution. The dye was left to diffuse for 10-15 minutes 
and the animals were then imaged inside a heated water bath (35°C). Ultrasound images 
were acquired to provide the anatomical structure of the hindlimb, and reconstructed using 
the synthetic transmit aperture (STA) method [53] (Figure 1.7(a)). PA images were then 
acquired for increasing pump-probe delay times, averaged over a hundred measurement to 
compensate for laser energy variations, and reconstructed using a backprojection algorithm 
(Figure 1.7(c)). The total PA image acquisition lasted approximately 150 seconds. Finally, 
the PALI image was reconstructed by first subtracting the background tissue signal (Figure 
1.7(b)) from the PA images and then calculating the lifetime for each pixel (Figure 1.7(d)). 
A hypoxic region was found at the site of the tumor, whereas normal tissue showed an 
oxygenation within the normal physiological range (Figure 1.7(e)). 
τ"τ = 1 + 	k(τ"pO+ 
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Figure 1.7. (a) Ultrasound image of the left tumor-bearing hindlimb of a mouse. The area of the tumor is 
enclosed by a red dashed line. (b) Background tissue absorption at 810 nm. (c) Transient PA amplitude at a 
pump-probe delay of 0.25 µs. (d) pO2 map obtained from PALI (e) Transient PA amplitude of two 
representative pixels within the tumor and in normal control tissue. The error bars represent the standard 
deviation over 100 recordings. The dashed lines represent the exponential fitting curve.1  
                                                
1 Animal work and data analysis were performed by Q. Shao [52] 
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1.2.4   Current activatable probes for photoacoustic imaging 
The advantages of PA imaging have led to the recent development of several 
photoacoustic activatable probes to image the activity of proteolytic enzymes [54-56]. 
These probes are comprised of a fluorophore-quencher pair held together by a peptide 
linker or structure with one or more activation sites. Nearly invisible in their inactive state, 
they can be switched on upon interaction with a target enzyme.  
Regression analysis is used to measure differences in photoacoustic absorption 
arising from probe activation. Ideally, the number of wavelengths used to resolve changes 
in the absorption spectra should be at least equal to the number of independent components 
in tissues (inactive and active probe, hemoglobin, deoxyhemoglobin, etc…). The 
underlining assumption is that the PA signal is a linear function of the absorption spectrum 
of the tissue components. This assumption, however, only holds in an approximate way at 
shallow depths. As light penetrates deeper into the tissue, its spectral distribution changes 
due to the absorption by endogenous chromophores. It also changes due to scattering which 
is wavelength dependent. Thus, the spectral shape of the illumination at a fixed point in the 
tissue is not known, and therefore the PA signal generated at this point does not reflect the 
true absorption spectrum. The situation is akin to having an optical spectrometer without 
the option of taking a reference spectrum for compensating the spectral shape of the lamp. 
This inherent non-linearity of multi-spectral PAI is well known and has been addressed by 
several groups [57, 58]. This effect limits imaging of activatable probes by PA imaging 
due to the difficulty in suppressing tissue background and non-activated probe signal.  
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1.2.5 Activatable photoacoustic lifetime probe  
For my dissertation, I developed a more robust activatable probe design based on 
the lifetime contrast between the inactive and active form of the probe. Efficient 
intersystem crossing to the metastable triplet state in MB monomers results in long 
excitation lifetime. MB dimers, on the other hand, have a very short lifetime due to static 
quenching. Furthermore, in addition to absorbing weakly at the wavelengths used to excite 
and probe excited-state MB, the lifetime of relevant tissue components is at least three 
orders of magnitude shorter than that of MB monomers (Table 1.1). These properties can 
be exploited to design a dually-labeled activatable probe which produces extremely high 
contrast. The distinct separation of time-scales allows for efficient suppression of all PA 
signals arising from absorbers having lifetimes shorter than a set threshold.  
 
 
 
 
 
 
 Table 1.1: Excited-state lifetime of activatable lifetime probe in its two states and main tissue components.  
 
 
Molecule Lifetime (ns) 
Myoglobin 0.1 [59] 
Melanin 0.14 [60] 
Albumin 4.8 [61] 
Deoxyhemoglobin 0.2 [62] 
Oxyhemoglobin 0.22 [62] 
MB dimers/inactive probe 40 [63] 
MB monomers/active probe > 1800 [51] 
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MB dimerization and lifetime are affected by changes in pH and temperature. 
Previous studies showed that the pH of tumors is significantly lower and exhibits more 
variability (from about 5.8 to about 7.6) than the pH of surrounding tissues (from 7.00 to 
8.06) [64]. Absorption measurements of potassium phosphate buffered MB solutions (pH 
5-8) revealed that pH levels in that range do not have a considerable effect on MB 
dimerization compared to the aggregative effect of sodium sulfate, a salt known to 
artificially increase MB dimerization and studied in Chapter 2 (Figure 1.8). Similarly, an 
increase in temperature has a disaggregating influence on the absorption spectrum of dimer 
dyes [65], but this effect is insignificant compared to that of salt-induced dimerization. 
Finally, it should be noted that at pH < 6 the excited-state lifetime was shown to decrease 
from 36 to 4 µs in nitrogen purged solution [66]. 
 
 
Figure 1.8. Dimer-to-monomer ratio of MB at different pH levels and different sodium sulfate (Na2SO4) 
concentrations. The error bars represent the standard deviation over 3 measurements. 
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Chapter 2. A chemical model for MB dimerization 
Photoacoustic lifetime contrast between methylene blue monomers and self-quenched 
dimers as a model for dual-labeled activatable probes. 
 
2.1   INTRODUCTION 
Photoacoustic molecular imaging is a non-ionizing modality that provides high 
penetration depth and high spatial resolution information on the functional and metabolic 
status of diseases at greater depths than other optical imaging techniques [41, 55, 56]. 
Traditionally, photoacoustic imaging has been used with both endogenous (e.g. 
hemoglobin and melanin) and exogenous contrast agents that exhibit higher optical 
absorption than normal tissue. Targeting molecular markers using exogenous smart probes 
can potentially reap valuable information about biological processes occurring at different 
stages of various diseases. As a result, photoacoustic molecular imaging could substantially 
aid the diagnosis of cancer by detecting subtle abnormalities at the molecular level well 
before the appearance of anatomical changes [67]. This capability would also allow for 
personalized treatment planning and step-by-step evaluation of treatment efficacy [56]. 
Our research focuses on the development of a new photoacoustic contrast agent 
based on the lifetime sensing of methylene blue (MB) dye. MB monomers present a high 
quantum yield of intersystem crossing (ΦISC > 0.50) [68] and a long triplet excited-state 
lifetime (τ > 70 µs) [51]. Upon aggregation, static quenching between strongly bonded 
molecules dramatically shortens their excited-state lifetime by two to three orders of 
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magnitude [69]. This forms the basis of a highly-sensitive contrast mechanism between 
MB monomers and dimers. A promising application is the development of a MB-labeled 
smart probe activated by enzymatic cleavage. The probe’s signal is highly suppressed in 
the bound state, but it recovers its long excited-state lifetime after activation, which is then 
detectable by photoacoustic lifetime contrast imaging (PLCI) (Figure 2.1). 
 
 
Figure 2.1. Schematic representation of proposed MB dual-labeled activatable probe containing a specific 
enzymatic site. The intact probe has a short lifetime of a few tens of nanoseconds. Enzymatic cleavage 
separates the chromophores thereby permitting them to recover their long excited-state lifetime (tens of 
microseconds). 
 
2.1.1   Activatable probes for molecular imaging 
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Activatable probes are a class of contrast agents that identify selective enzyme 
activity by switching from an inactive state to an active state upon interaction with a target 
enzyme [20]. Originally developed for fluorescence imaging, the probes contained a 
fluorophore-quencher pair coupled to a peptide linker bearing an enzymatic site [70]. Upon 
cleavage of the linker, the pair is separated and fluorescence is restored. This approach 
provides high contrast because of the low fluorescence background of the uncleaved, 
inactive form. Additionally, the fluorescence signal is further amplified due to the 
activation of multiple probes by a single enzyme [14]. 
Activatable fluorescent probes have been successfully used in a wide range of 
small-animal imaging studies. The short penetration depth of light in tissue due to strong 
optical attenuation and scattering, however, limits their translation to clinical applications 
and leads to poor spatial resolution beyond a few millimeters [21]. Photoacoustic imaging 
has emerged in the last two decades as an alternative optical modality offering significantly 
improved resolution (up to 0.02 mm) and penetration depth (up to 5 cm) in tissue imaging 
[41]. Its application has been demonstrated in clinical studies for skin cancer diagnosis [71] 
and breast cancer screening [72]. 
Activatable photoacoustic probes have recently been proposed and studied by 
several groups [55, 56]. They rely on a change in the absorption spectrum upon activation 
to selectively detect the activated probe signal. This method requires multi-wavelength 
illumination to resolve the spectral contribution of each chromophore by linear fitting and 
assumes that the spectral distribution of probes and tissue absorbers is known. In practice, 
non-uniform light distribution due to wavelength-dependent attenuation and heterogeneous 
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optical properties of tissue hamper accurate spectral identification and background signal 
suppression. 
 In this work, we propose a new photoacoustic contrast mechanism that is based on 
switching the excited-state lifetime of the probe from short (< 100 ns) to long (> 2 µs). 
PLCI - a pump-probe approach that eliminates the need for spectral deconvolution by 
measuring lifetime contrast using only two illumination wavelengths - is applied for the 
first time to selectively detect the signal from activated probes.   
2.2.2 Photoacoustic lifetime contrast imaging 
Methylene blue is a planar cationic and water-soluble dye of the phenothiazine 
family with an absorption peak at 664 nm in its monomer form (Figure 2.2). It is commonly 
used, or under study, in several therapeutic and diagnostic applications [73, 74]. Both orally 
and intravenously administered MB are excreted by the kidneys, either unchanged or 
reduced to leucomethylene blue by the enzyme methemoglobin reductase present in red 
blood cells [75, 76].  Following optical absorption, the ground state molecule (S0) is excited 
into a singlet state (S1), and then undergoes intersystem crossing (ISC) to a metastable 
triplet state (T1) with high quantum yield (ΦISC =/0.50) [68] (Figure 2.3). The excited triplet 
state lifetime is typically tens of microseconds in an oxygen-free environment because of 
the spin-forbidden nature of the T1-S0 transition. Collisional quenching by oxygen 
decreases the lifetime to about 2 µs in aerated solutions at atmospheric pressure [39].  
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Figure 2.2. Absorption spectra of MB in water (2 µM to 200 µM). The absorption maximum shifts from 665 
to 608 nm with increasing [MB] indicating an increase in the dimer-to-monomer molar ratio. The isosbestic 
point at 625 nm is shifted towards the blue wavelengths for MB > 100 µM due to the formation of higher 
order aggregates. 
Molecular association between monomers occurs spontaneously in water due to a 
combination of hydrophobic interactions, hydrogen bonding and Van der Waals forces [77, 
78]. The coupling between monomers results in a splitting of the singlet excited state into 
two states - of lower and upper energies – which manifests by a splitting of the absorption 
band of the monomer (Figure 2.3) [77, 79-81]. Figure 2.2 shows a shift in the absorption 
peak from 665 nm to 608 nm with increasing MB concentrations. This corresponds to the 
preferential transition to a higher energy state resulting in a dominant blue-shifted peak 
specific of H-type (or face-to-face) dimers. If a dimer is excited to the upper state S1, it 
undergoes very fast (10-12 s) internal conversion to the lower state S1’, and, because 
transitions from S1’ to S0 are forbidden, intersystem crossing is enhanced. If the coupling 
between monomers is strong, electron transfer is expected to occur between the pair 
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resulting in triplet lifetime quenching and formation of transient radical ion pairs [82, 83]. 
Excitation of an aqueous MB solution revealed the existence of a fast transient derived 
from the dimer, allegedly a triplet state, which decays into a slow transient pair formulated 
as a charge-transfer [84]. In an experiment mixing MB with sodium dodecyl sulfate - a 
compound that promotes MB dimerization at specific concentrations - Junqueira et al. 
reported lifetimes of 40 ns, 1.6 µs and 300 µs for the triplet, radical anion and radical cation 
respectively [63]. 
 
Figure 2.3. Energy diagram of MB monomer and dimer. Plain lines represent radiative transitions. Small 
dashed lines represent nonradiative processes. The energy of the T1:T2 absorption is converted into a 
photoacoustic relaxation signal. The double bar indicates a discontinuity in the transition diagram: the dimer 
triplet undergoes electron transfer (~ 40 ns) which leads to the formation of oppositely charged radicals that 
relax to the ground state via charge recombination (~10-6 to10-4 s). S0: ground state, S1: singlet excited state, 
T1: primary triplet excited state, T2: secondary triplet excited state, S1’ and S1’’: split exciton states, ISC: 
intersystem crossing, IC: internal conversion. Bottom: configurations of MB monomer and H-type dimer. 
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PLCI is a pump-probe approach that consists of applying an initial laser pulse 
(pump) to excite the dye to the T1 state and a secondary pulse (probe) to excite T1 to a T2 
state resulting in ultrasound waves generated during the T2 → T1 photoacoustic relaxation 
(Figure 2.3). With this technique, the amplitude of the measured photoacoustic signal 
corresponds to the sum of the lifetime-dependent photoacoustic relaxation - a quantity 
proportional to the optical absorption of the T1 state - and the lifetime-independent 
background photoacoustic signal due to the excitation of the background environment by 
the probe pulse. By repeating a sequence of pulse pairs with different time delays between 
pump (dye excitation) and probe (photoacoustic wave generation) pulses, we can measure 
the decay dynamics of the triplet state and extract the excitation lifetime by exponential 
fitting. This technique has been recently demonstrated for quantitative measurement of 
dissolved oxygen levels in phantom objects by our research group [39]. 
 
Figure 2.4. Normalized transient photoacoustic signal for MB monomer (τ = 4 µs), dimer (τ = 40 ns), and 
hemoglobin (τ = 0.22 ns).  
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The distinct separation of lifetimes between MB monomers, MB dimers, and main 
biological components – the lifetime of hemoglobin, albumin, myoglobin and melanin fall 
in the range of several tenths to several nanoseconds [59-62] – can be exploited to 
efficiently suppress all photoacoustic signals arising from absorbers having lifetimes 
shorter than a set threshold. Figure 2.4 shows the normalized photoacoustic signal of 
hemoglobin, MB dimers and MB monomers in low oxygen environment measured after 
probe excitation in a uniformly illuminated sample. Since MB monomers and dimers do 
not absorb at the probe wavelength (800 to 850 nm) [85],  the background photoacoustic 
signal is constant and equal to the value after complete relaxation of the chromophores, i.e. 
PA100 µs. By subtracting two photoacoustic signals taken with a pump-probe delay of 1 µs 
and 100 µs, the only contribution comes from monomers. Additionally, dividing the 
difference signal by PA100 µs normalizes the monomer signal to the probe laser energy 
which corrects for energy deposition fluctuations within the illuminated sample. A 
photoacoustic contrast parameter as defined in (1) is proportional to the monomer 
concentration:  
 1 µs 100 monomerPLCI
bac
 µs
100 µs kground
PP AC = [monomer]
P
A - 
A
PA
PA
= µ   (1) 
2.2.3 Study goal 
The goal of this study was to investigate two dimerization models to validate the 
contrast mechanism between MB monomers (activated probes) and dimers (inactive 
probes). The first system involves sodium-sulfate-driven dimerization caused by the 
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increase of hydrophobic interactions with ionic strength. The second system incorporates 
dimerization induced by sodium dodecyl sulfate premicellar aggregates. We have used 
these two systems to switch between high dimer concentration and high monomer 
concentration, and to demonstrate that PLCI can achieve an efficient suppression of the 
dimer signal relative to that of the monomer.    
 
2.2 MATERIALS AND METHODS 
2.2.1 Materials 
Methylene Blue hydrate (purum ≥ 97%), and sodium dodecyl sulfate (≥ 99.0%) 
were acquired from Sigma-Aldrich (St. Louis, MO) and sodium sulfate anhydrous (ACS) 
was acquired from Mallinckrodt Chemicals (Phillipsburg, NJ). All chemicals were 
dissolved without further purification in distilled water. Absorption and flash-photolysis 
measurements involving SDS were completed within 3 minutes after MB dilution. 
Experiments were performed at 22 ± 1 °C, and the pH of the solutions was measured to be 
within 6.7 ± 0.9. Changes in temperature and pH level in these ranges do not have a 
significant effect on MB dimerization.  
2.2.2 Absorption measurements 
Absorption spectra were recorded on a UV/Vis CaryUV Varian spectrophotometer 
using glass and plastic cuvettes of 0.1, 0.5 and 1 cm thickness. Triplet transient absorption 
was measured independently from PA experiments at fixed wavelengths by laser flash 
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photolysis. The pump pulses were generated by an optical parametric oscillator (OPO, 
Opotek MagicPrism) pumped by a tripled Nd:YAG pulsed laser (Surelite I-10, Continuum, 
f = 10 Hz, pulse width = 5 ns). The solution-filled cuvettes were probed by a laser diode (λ 
= 808 nm, P = 150 mW) emitting continuously at a right angle with respect to the pump 
laser beam. The probe beam, once transmitted through the sample, is bandpass filtered 
(Thorlabs, FB810-10, central frequency = 810 nm) and measured by a Si photodetector 
(Thorlabs, DET10A).  The signal is recorded by a digital oscilloscope (Lecroy, Wavejet 
354) and transferred to a computer for processing. All the experimental data were 
processed and analyzed with MATLAB. 
2.2.3 Photoacoustic experimental setup 
A PLCI experimental setup was used to probe the photoacoustic signal of plastic 
tubes filled with dye or mixed salt/dye or SDS/dye solutions as illustrated in Figure 2.5. 
Two tunable Nd:YAG pulsed-laser systems (Surelite I-10, Continuum; Quantel, Brilliant; 
both: f = 10 Hz, pulse width = 5 ns), each coupled to an OPO (Opotek MagicPrism), 
delivered the pump and probe pulses (6 and 8 mJ respectively). The output of both OPO 
systems was coupled to a bifurcated light guide (Dolan-Jenner, EE436, non-randomized 
for salt experiment; or Moritex, MWG-1000S-SD, randomized for SDS experiment) to 
ensure uniform illumination of the plastic tubes. The tubes were immersed in a water tank, 
and a focused ultrasound transducer (Panametrics, V382, 3.5 MHz for salt experiment; or 
V311, 10 MHz for SDS experiment) aligned with the incident laser beams detected the 
photoacoustic signals generated in the samples. Laser firing and ultrasound acquisition 
were synchronized by a field-programmable gate array (FPGA, KNJN, FX2 Saxo). Signals 
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were amplified by 50 dB (Panametrics, 5072PR), recorded by a digital oscilloscope 
(Lecroy Wavejet 354), and transferred to a computer for processing. B-mode images were 
acquired by scanning the tubes perpendicular to their long axis using a motorized actuator 
(T-LA28A, Zaber) mounted on a translation stage. To maximize contrast, the wavelengths 
of both beams were independently tuned near the maximum of absorption for the monomer 
and triplet species and within the range of maximal output energy for the OPOs. 
 
Figure 2.5. PLCI experimental setup. Pulsed outputs of the excitation laser (660 nm) and photoacoustic laser 
(840 nm) were combined with a bifurcated light guide and illuminate the target. The time delay between the 
excitation and probe pulses was controlled by an electronic synchronization circuit. The solutions were placed 
in two plastic tubes and scanned horizontally. The generated acoustic waves were detected by a focused 
ultrasound transducer. Sync out: synchronization output. 
 
2.2.4 Calculation of monomer and dimer concentrations 
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The individual monomer and dimer spectra were obtained using a two-state model 
analysis of the spectral data in the concentration region where the monomer-dimer 
equilibrium is dominant (2 µM to 50 µM), as indicated by a stable isosbestic point at 625 
nm (Figure 2.2). For concentrations greater than 50 µM, we observed a progressive blue 
shift of the isosbestic point that can be attributed to the formation of a small amount of 
trimers (with absorption maximum at 580 nm) [86].  In this model (adapted from Patil et 
al. [78]), the dimer dissociation constant KD is defined as (2): 
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where C is the total concentration of the dye; C = [M] + 2[D], and xM is the monomer molar 
fraction; xM = [M]/C. If we assume that we have only two species in solution, then the 
Beer-Lambert law is applicable to those species (3):  
 λ λA   ε l C= × ×   (3) 
where the observable molar absorption coefficient ελ can be expressed as a function of the 
individual molar absorption coefficient of the monomer ε-.  and the dimer ε/. /2 (4): 
 λ λ λM M M Dε  x ε  (1 x )ε / 2= + -   (4) 
also written in the linear form (5): 
 λ λ λ λM M D Dε x * (ε  ε / 2) ε / 2= - +   (5) 
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We computed a linear regression to model the relationship between the molar 
absorption coefficient ελ, measured for different concentrations, and the monomer molar 
fraction at those concentrations to calculate the value of the dissociation constant KD that 
minimizes the sum-of-squared residuals over several wavelengths. We found a KD value 
of 2.6 x 10-4 M which is in good agreement with the value reported by Patil et al. (2.9 x 10-
4 M, at 27 °C) and by Rabinowitch and Epstein  (2.8 x 10-4 M, at 26.7 °C) [65]. 
The εM
 and εD/2 values at different wavelengths were extracted from the slope and 
origin of the linear fit and used to generate the individual monomer and dimer spectra 
(dashed lines in Figure 2.6 (a)). Assuming a two-component system, we can use a 
rearranged form of eq. (4) to establish a concentration-independent relationship between 
the dimer-to-monomer absorption peak ratio and the true monomer molar fraction (6):  
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2.3 RESULTS AND DISCUSSION 
2.3.1 Dimerization in sodium sulfate 
MB dimerization can be enhanced by increasing the ionic strength of the solution 
as accomplished by adding salts such as sodium sulfate [87]. Figure 2.6(a) represents the 
absorption spectra of MB 80 µM for increasing Na2SO4 concentrations, along with the 
individual monomer and dimer spectra calculated by applying a two-state model analysis 
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to the data obtained in water. The spectra have been normalized to the isosbestic point to 
compensate for small concentration variations due to dilution uncertainty, and a correction 
factor was calculated. The blue shift of the absorption maximum from 665 nm to 608 nm 
indicates that dimerization is enhanced with increasing salt concentration. The dimer peak 
does not exhibit a significant blue shift compared to the sole dimer spectrum (< 1 nm for 
[Na2SO4] = 0.75 M), therefore we conclude that trimerization does not perturb the 
monomer-dimer equilibrium significantly, and we adopt the two-state model for the 
evaluation of the monomer fraction in each case.  
 
Figure 2.6. (a) Solid lines: absorption spectrum of a solution of MB 80 µM for four different salt 
concentrations. Dashed lines: individual MB monomer (black) and dimer (gray) spectra in water. (b) 
Transient absorption (TA) of a solution of MB 80 µM with (orange) and without Na2SO4 0.8 M (blue) 
measured by flash photolysis. Top: λexc = 660 nm. Bottom: λexc = 625 nm (c) Transient photoacoustic signal 
amplitude as a function of pump-probe delay time acquired at four different Na2SO4 concentrations, 0 M (Δ), 
0.25 M (□), 0.5 M (○), and 0.75 M (◊). Inset: the photoacoustic contrast parameter was observed to be linearly 
dependent on the estimated monomer concentration (R2 = 0.9980). 
 We measured the triplet transient absorption of a solution of MB 80 µM with and 
without Na2SO4 0.8 M using flash-photolysis for λexc = 660 nm (Figure 2.6(b, top) and 
observed that the amplitude of the signal decreases with the addition of salt while the 
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lifetime remains unchanged. To ensure that this decrease is not due to a difference in 
absorption at the excitation wavelength, the experiment was repeated for λexc = 625 nm 
(Figure 2.6(b), bottom) and yielded the same qualitative results. This indicates that MB 
dimers are statically quenched and that their triplet excited-state lifetime is short. 
 Finally, photoacoustic probing of the MB/salt solutions was performed in a single 
tube.  MB monomers were excited at 660 nm, and the triplet decay was probed at 800 nm 
for increasing pump-probe delay times. Figure 2.6(c) shows that the amplitude of the 
photoacoustic signal decreases with the salt concentration, which is in agreement with the 
flash-photolysis results. The photoacoustic contrast parameter was calculated between 1 µs 
and 100 µs and plotted against the estimated monomer concentration (inset Fig. 2.6(c)) 
which was obtained by multiplying the monomer molar fraction by the total MB 
concentration adjusted by the correction factor found from the absorption spectra. CPLCI at 
the plastic-wall interface is in linear relationship with the monomer concentration (R² = 
0.9980). We believe that the non-zero origin may be explained by an overestimation of the 
monomer concentration or a difference in local light distribution between 1 µs and 100 µs. 
2.3.2 Dimerization in sodium dodecyl sulfate 
Despite their ability to increase dimer formation, salts have a limited power to 
overcome strong repulsive forces between MB molecules and do not induce full 
dimerization even at concentrations close to the solubility limit. Sodium dodecyl sulfate 
(SDS), on the contrary, is an anionic surfactant that binds MB due its opposite charge and 
provides a hydrophobic microenvironment that promotes dye aggregation on a larger scale. 
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SDS concentrations as low as 1 mM have been shown to significantly increase MB 
dimerization [63, 69, 88]. The following experiments were realized within 3 minutes after 
MB dilution to ensure that the solutions remained stable over time. 
Absorption measurements (Figure 2.7(a)) revealed that the progressive addition of 
SDS to a 100 µM MB solution shifts the absorption maximum from 665 nm to 595 nm 
thereby revealing the formation of H-type dimers (λmax = 608 nm), and even higher order 
aggregates with lower absorption maxima. This is paralleled by a decrease in the triplet 
transient absorption measured by flash photolysis for λexc = 660 nm (Figure 2.7(c)). A 
maximum of polymerization occurs for [28] ≈ 4 mM (Figure 2.7(b)) which corresponds to 
a minimum and a 25-fold decrease in the triplet transient absorption signal (Figure 2.7(c)). 
The same experiment conducted for λexc = 600 nm - a wavelength for which the extinction 
coefficient of dimers is twice the extinction coefficient of monomers - led to the same trend 
and a maximum of polymerization at 4 mM as well. Finally, we observed that the maximum 
of polymerization is invariant with respect to MB concentration by repeating the 
experiment for MB = 40 µM and for MB = 200 µM. 
Junqueira et al. showed that the presence of increasing amounts of MB in SDS 
solutions decreases the critical micelle concentration (CMC) below the known CMC in 
water (7-8 mM) [63]. Carroll et al. demonstrated that the scattering signal from a 1 µM MB 
solution exhibits a strong signal for [28] = 1.5 to 4.5 mM, suggesting the presence of a 
large aggregate in that range [88]. Those results indicate the formation of MB-SDS clusters 
or premicellar aggregates before the CMC is reached. We suggest that these pre-micelles 
are formed by strong electrostatic interactions between anionic SDS and cationic MB with 
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the surfactant possibly intercalating its hydrophobic tail between adjacent MB molecules 
(Figure 2.7(d)). Water molecules might also help stabilize the MB/SDS complex by 
forming a hydrogen-bonded, shell-like structure called an “iceberg structure” [89]. The 
distance between MB molecules inside the pre-micelles are short (corresponding to high 
local concentration) which promotes dimer formation.  
 
Figure 2.7. (a) Solid lines: absorption spectrum of a solution of MB 100 µM (x
M
 = 0.65) for six different 
SDS concentrations. Dashed lines: individual MB monomer (black) and dimer (gray) spectra in water. (b) 
Dimer-to-monomer absorption peak ratio versus SDS concentration. (c) Triplet transient absorption 
measured at t = 0+ after excitation (660 nm) versus SDS concentration. (d) Schematic representation of 
MB/SDS interactions at different SDS concentrations. The data points in (b) and (c) were obtained by 
averaging three independent measurements and normalizing to the signal measured in the absence of SDS. 
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At intermediate surfactant concentrations (4.5 < [28] < 7 mM), the monomer 
fraction increases progressively while the triplet transient absorption remains low. Previous 
groups attributed this behavior to the reorganization of MB/SDS clusters as a prelude to 
the formation of normal micelles. During this stage, pre-micelles may be disaggregating 
with MB molecules released as MB/SDS quenched ion pairs [69, 88]. 
Finally, at SDS concentrations greater than 7 mM, the triplet transient absorption 
increases logarithmically until reaching a plateau corresponding to full monomerization. 
Concurrently, the absorption maximum at 665 nm is blue-shifted compared to the monomer 
spectrum, signifying that the monomers are surrounded by a more polar environment than 
in water without SDS (most likely the inner hydrophobic microenvironment or the 
negatively-charged surface of the micelle) (Figure 2.7(d)). Therefore, the increase in 
monomer fraction can be explained by the increase of available sites for MB molecules to 
bind as the number of micelles increases. 
In conclusion, a SDS concentration of 4 mM effectively promotes MB 
polymerization by playing a cross-binding role between the dye molecules. The large 
extent of polymerization (more than 95 % of the initial monomers were transformed) makes 
this system a valuable tool for modeling the activation of a cleavable probe by 
photoacoustic contrast imaging.  
2.3.3 PLCI imaging between MB monomers and dimers in SDS 
Two plastic tubes respectively containing 200 µM MB + 4 mM SDS (top) and 200 
µM MB (bottom) solutions were scanned by the PLCI system (Figure 2.8(a)). We estimated 
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that the samples contained 5 µM and 110 µM monomer concentrations respectively. For 
this estimation, we first determined the monomer concentration in absence of SDS by 
applying the methodology described in 2.2.4 to the absorption spectrum of the MB-only 
sample. Because the addition of SDS induces the formation of a non-negligible amount of 
trimers, we cannot use eq. 6 to evaluate the monomer concentration of the second sample 
from the absorption spectrum. Alternatively, we determined this concentration by 
multiplying the monomer concentration in the absence of SDS by a proportionality factor 
corresponding to the difference in transient absorption between the two samples obtained 
by flash photolysis. 
The samples were probed by a 10 MHz ultrasound transducer scanned 
perpendicularly to the tube axis within a range of 8 mm and with step size 0.2 mm. The 
signals were averaged over 32 measurements to compensate for pulse-by-pulse energy 
variations. The scanning time was relatively short (40 minutes) such that a majority of 
dimers (90%) remained stable during the experiment. At each step we calculated the 
photoacoustic probe signal by subtracting the signal generated without the probe 
(excitation only) to the signal recorded with both beams (excitation + probe): PA840 (t = τ) = 
(PA660+840 - PA660) t = τ. As ground state MB does not absorb at the probe wavelength (840 
nm) [85], the signals measured at 100 µs correspond to the photoacoustic energy generated 
by the static background. The difference between the signal at 1 µs and the signal at 100 
µs was computed to suppress the contribution of the background signal. The signals were 
processed with a Wiener filter followed by a low-pass filter (Butterworth, 6th order, cut off 
frequency at 6 MHz). The envelope was detected by the Hilbert transform method. 
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Figure 2.8. (a) Schematic representation of the position and size of the plastic tubes. Monomer concentrations 
are given in each case. (b) Photoacoustic amplitude image at 840 nm recorded 1 µs after the excitation pulse 
shows the signal generated at the plastic wall–solution interfaces. (b) Photoacoustic amplitude image at 840 
nm recorded 100 µs after the excitation pulse. (d) Difference between photoacoustic amplitude images at 1 
µs and 100 µs. There is a 21.5 dB suppression of the background signal due to the short lifetime of MB 
dimers. The numbers represent the value of the contrast parameter C
PLCI
 at the front wall of the tubes.  
Photoacoustic images corresponding to 1 µs (PA840 (t = 1 µs)) and 100 µs (PA840 (t = 100 
µs)) are displayed in Figure 2.8 on a 20 dB scale as well as their difference. The circles 
correspond to the location and size of the plastic tubes. Dimer and background signals are 
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efficiently suppressed by -21.5 dB in the differential image with a noise level of -59 dB 
(Figure 2.8(d)). The contrast parameter, calculated for the front wall of each tube, decreases 
by an average factor of 10 for the MB/SDS solution. Although CPLCI is no longer 
proportional to the monomer concentration, possibly due to significant scattering in the 
MB/SDS solution, these results indicate that PLCI efficiently detects the monomer signal 
in a phantom object. 
 
2.4. CONCLUSION 
Here we present a new contrast mechanism for photoacoustic imaging based on the 
difference in excited-state lifetime between monomer and dimer forms of a chromophore. 
We have studied two model systems to demonstrate the sensitivity of the PLCI method to 
aggregation states of MB dye. The addition of salt (sodium sulfate) provides a simple and 
direct way to change the self-association constant of MB solution and therefore the 
equilibrium dimer-to-monomer ratio. We have shown that the PLCI signal depends linearly 
on the monomer concentration as measured by analysis of optical absorption spectra. A 
second model system makes use of a surfactant (SDS) to induce MB dimerization. After 
careful study of the system, an optimal SDS concentration was identified that results in 
maximal dimerization of MB. This concentration is lower than the critical micelle 
concentration of SDS in aqueous solution, which implies that MB-SDS aggregates form 
pre-micellar structures. The PLCI imaging experiment reveals a contrast of more than 20 
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dB between two samples of equal MB concentration, one containing free MB solution and 
the other containing SDS-MB for maximal MB dimerization. 
Activatable smart probes have been developed as research tools for studying protein 
conformational dynamics [90, 91], for detecting nucleic acid hybridization [70, 92], and 
for sensing enzymatic activity of disease biomarkers [16, 19, 93, 94]. Based on the previous 
measurements, we propose a new mechanism for an activatable photoacoustic probe.  In 
its simplest form, the probe relies on a custom-made peptide linker bearing a specific 
enzymatic site and confining two MB molecules to a dimer configuration. This 
configuration results in an intact, quenched probe of short lifetime. Reaction with 
endogenous enzymes cleaves the linker and separates the probe into MB monomers. The 
PLCI system would be used to selectively detect the long-lifetime signal from activated 
probes (monomers), which would provide a map of both enzyme location and activity. The 
lack of other long-lifetime molecules in the body empowers the sensitivity of this approach. 
We believe that PLCI probes could be implemented to investigate the role of specific 
enzymes in disease initiation and progression in animal models and establish pre-clinical 
data for translational research. Ultimately, PLCI probes could be developed as an early 
diagnosis tool and to monitor treatment efficacy.  
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Chapter 3.  
Engineering a Lifetime-Based Activatable Photoacoustic Probe for Matrix 
Metalloproteinase 2. 
 
3.1 INTRODUCTION 
Photoacoustic molecular imaging is a rapidly growing imaging modality that 
combines the selectivity of light-absorbing contrast agents with the relatively high spatial 
resolution and penetration depth of ultrasound imaging [95, 96]. Different types of 
photoacoustic imaging probes have been developed to visualize biological events [97, 98]. 
Early probe designs for cancer research have relied on passive uptake through the enhanced 
permeability and retention (EPR) effect to enter the tumor site [99], but they lack specificity 
and show high off-target signal [97]. Targeted photoacoustic probes can bind to a specific 
molecular marker such as cell surface receptors, transporters or enzymes, and accumulate 
at the target site [100], but since they continuously enable signal, they cannot provide 
functional information about dynamic events. A third class of photoacoustic contrast agents 
are activatable smart probes that can detect specific events by switching from a silent state 
to a detectable state upon cleavage by a target molecule, or conformational reorganization 
induced by environmental factors. Activatable photoacoustic probes can therefore provide 
low background noise and high imaging contrast [23, 61, 94, 101-108].  
Recently, several groups have developed activatable smart probes for photoacoustic 
imaging of enzymes [23, 55, 94, 109], copper(II) [102], reactive oxygen species [110], pH 
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[104, 105] and temperature [106], or demonstrated the use of commercially available 
activatable fluorescent probes with photoacoustic detection [54, 108]. Two common 
methods to detect the active probe signal include single and dual wavelength imaging. 
Single wavelength imaging maximizes photoacoustic emission by exciting at the maximum 
of absorption of the active probe signal [23, 105, 106, 108]. Dual wavelength imaging relies 
on a change in the absorption spectrum between the inactive and active forms of the probe 
to enhance contrast, using either spectral subtraction [55, 94] or ratiometric detection [102, 
104, 109, 110]. Both methods assume low and homogeneous absorption of background 
tissue absorbers and do not actively attempt to subtract the background noise. In practice, 
however, background absorption can vary significantly, and resolving the active probe 
signal may become challenging in the presence of highly absorbing and spatially 
heterogeneous tissue chromophores combined with low probe concentration. One strategy 
is to incorporate particles with high absorption capacity and high energy conversion 
efficiency into the probe design, such as semiconducting polymers [104, 110] or gold 
nanoparticles [105]. Alternatively, activated probes may be designed to aggregate locally 
resulting in photoacoustic signal amplification [23, 106]. Finally, Multispectral 
Optoacoustic Imaging (MSOT) is capable of extracting the probe signal by decomposing, 
or unmixing, a photoacoustic image based on the unique spectral signature of its 
photoabsorbing components [54]. In its simplest application, MSOT assumes prior 
knowledge of the absorption spectrum of each endogenous and exogenous absorber and 
performs a linear fit of the photoacoustic signal acquired at multiple excitation 
wavelengths.  
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Photoacoustic Lifetime Imaging (PALI) is an alternative imaging method that 
detects the excited-state lifetime of molecules using a two-step pump-probe approach. 
First, a laser pulse (pump) excites the molecule to a higher energy level. Then, a second 
laser pulse (probe) interrogates the optical absorption of the transient excited state by 
generating a transient photoacoustic signal. By scanning the time delay between the pump 
and probe pulses, the relaxation dynamics of this excited state can be captured. As 
endogenous tissue absorbers such as hemoglobin, melanin and albumin have small excited-
state lifetimes in the 0.1 – 10 ns range [59-62], PALI can ignore their photoacoustic signal 
by suppressing any signal under a set lifetime threshold. Photosensitizers such as 
methylene blue (MB) and some porphyrin derivatives show potential as photoacoustic 
lifetime contrast agents due to their long-lived triplet excited state [111, 112] as well as 
their high optical absorption in the red region of the spectrum, which has reduced 
absorption by native molecules [113]. In addition, we have previously shown that the 
dimerization of MB molecules led to the quenching of their photoacoustic lifetime in 
sodium sulfate and sodium dodecyl sulfate solutions [114]. Here, we considered whether 
PALI could be employed to resolve the activation of a cleavable smart probe labeled with 
two MB chromophores arranged in a dimer configuration. 
The probe was based on a design by Jiang et al. who developed an activatable cell-
penetrating peptide for fluorescence imaging comprising an electrostatic zipper [16]. After 
cleavage by the target enzyme, the polyarginine half of the probe enters the cells, resulting 
in signal accumulation [115]. This design was later modified by Levi et. al who evaluated 
two chromophore-quencher pairs for dual-wavelength photoacoustic imaging [55]. More 
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recently, Rood et al. developed a fluorescent activatable lifetime imaging probe using 
luminescence quenching [116]. Our photoacoustic lifetime-based activatable probe 
comprises a pair of MB chromophores conjugated to an electrostatic zipper and covalently 
linked by the MMP-2 specific recognition sequence PLGLAG (Figure 3.1). MB 
dimerization is facilitated by three mechanisms: a) the PLGLAG sequence, particularly the 
proline and glycines, enable a substantial ‘turn’ in the polypeptide backbone [117]; 2. b) 
electrostatic attraction between the two halves of the zipper bring MB molecules together; 
and c) intermolecular interactions between the methylene blue moieties. Cleavage of the 
probe by MMP-2 enzyme separates the two halves, and the chromophores recover their 
long excited-state lifetime.  
MMPs were chosen as a molecular target because of their role in regulating the 
tumor microenvironment and the signaling pathways involved in cancer progression [118]. 
MMPs degrade extracellular matrix proteins and various cell adhesion molecules, therefore 
enabling tissue remodeling during normal physiological processes and pathological states 
such as cancer progression and inflammation-related diseases [27, 119, 120]. Due to their 
ability to facilitate cell migration by rearranging the space around the cells, they are 
involved in tumor invasion and metastasis [121]. More recently, new roles of MMPs have 
been identified in tumor angiogenesis, apoptosis, inflammation, and adipogenesis, 
mediated by the degradation of non-matrix substrates and the release of growth factors 
[118]. MMPs and MMP inhibitors have been extensively studied as drug targets for cancer 
therapy, though treatments have yielded limited success, possibly due to the complexity of 
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their signaling network activity [38]. Hence, developing molecular tools to visualize MMPs 
is needed to better understand their role in disease initiation and progression.  
In this paper, we describe the synthesis and evaluation of several conjugated agents. 
First, we assessed the dimerization and quenching efficiency of a pair of MB chromophores 
covalently linked by a single lysine. Then we compared activatable peptide probes with 
varying electrostatic zipper lengths and with or without a flexible linker to gain insight into 
their functionality. 
 
 
Figure 3.1. The photoacoustic probe design is composed of a MMP-2 recognition sequence PLGLAG, an 
electrostatic zipper comprising cationic poly-D-arginine (r+) and anionic poly-D-glutamate (e-) domains, a 
flexible linker (z) and a pair of MB chromophores. The intact probe is hypothesized to have a short lifetime 
of tens of nanoseconds due to static quenching. Upon cleavage of the recognition sequence, thereby 
elimination of the indirect covalent linkage, the electrostatic zipper is insufficient to maintain MB 
dimerization. MB monomers separate and exhibit long lifetime (1-10 microseconds). 
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3.2 MATERIALS AND METHODS 
3.2.1 Materials  
Methylene blue hydrate (purity ≥ 97%) and methylene blue N-hydroxysuccimide 
ester (MB-NHS) were acquired from Sigma-Aldrich (St. Louis, MO) and ATTO-TEC 
(Siegen, Germany), respectively. L-lysine was purchased from Sigma-Aldrich, and 
activatable peptides were purchased from United Peptide (Herndon, VA). Recombinant 
human MMP-2 proenzyme was from Calbiochem. p-aminophenylmercuric acetate 
(APMA) (toxic; use proper safety precautions) was from Sigma-Aldrich. TCNB buffer was 
prepared by mixing 50 mM Tris-HCl, 10 mM CaCl2, 150 mM NaCl and 0.05% (w/v) Brij-
35 (Technicon), and adjusting the pH to 7.5 by adding 1M HCl.  
3.2.2   Synthesis of MB-lysine conjugates 
 MB-NHS ester and L-lysine were resuspended in dry DMSO to 20 mg/mL and 2.2 
mg/mL, respectively. A 3-fold molar excess of L-lysine was added to the MB-NHS 
solution to ensure both MB-K and MB2-K as products, along with 2% v/v trimethylamine. 
This mixture was left to react protected from light at room temperature for 2 hours. The 
samples were then purified using a C18 reverse-phase HPLC purification column with a 
solvent gradient of 22.5-67.5% acetonitrile in water with 0.1% trifluoroacetic acid. 
Individual peaks containing dually and singly labeled conjugates were collected and 
analyzed via electrospray ionization mass spectrometry (MALDI-TOF/TOF 5800, Applied 
Biosystems-Sciex Framingham, MA). Finally, the samples were lyophilized and stored at 
4°C prior to testing. 
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3.2.3   Synthesis of activatable peptide probes and their controls 
Peptides were resuspended in distilled water or buffer solutions of phosphate-
buffered saline (PBS) and 0.2 M sodium bicarbonate (20:1 v/v) with a final pH of 8.3. To 
conjugate each peptide terminus with MB, a 3-6 molar excess of MB-NHS resuspended in 
DMSO (20 mg/mL) was added to each peptide solution and allowed to incubate for > 24 
hours protected from light at room temperature. The samples were then purified via 
reverse-phase HPLC using C18 reverse-phase HPLC purification column with varying 
gradients of water/acetonitrile and 0.1% TFA.  Peaks containing dually-labeled peptides 
were collected. Peak purity > 95% was verified via mass spectrometry, with lower purity 
samples undergoing further reverse-phase HPLC purification. Purified probes were 
lyophilized and stored at 4°C, and resuspended before use.  Prior to each experiment, the 
absorption spectra of the probes were verified to be invariant with concentration (data not 
shown), indicating that no significant cleavage took place prior to enzymatic incubation.  
3.2.4   Absorbance spectra 
All MB-lysine conjugates and activatable peptide compounds were first solubilized 
in distilled water and then diluted to their working concentration in distilled water or PBS 
before testing. Absorption spectra were measured using 384-well microplates with a 
SpectraMax Plus 384 spectrophotometer (Molecular Devices, CA) or a Synergy H1 
spectrophotometer (BioTek, VT). The pure monomer and dimer spectra were obtained 
from a two-state linear regression model of MB dimerization described previously [114]. 
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Total molar concentrations were calculated using Beer Lambert’s law and the extinction 
coefficient of MB at the isosbestic point (35,700 M-1.cm-1) calculated with this model. 
3.2.5   Enzyme kinetics 
MMP enzymes become active after cleavage of their inhibitory N-terminal domain 
[122]. MMP-2 proenzyme was activated by incubating a 1:9:1 v//v ratio of MMP-2, TCNB 
buffer and 11 mM APMA freshly dissolved in 0.1 M NaOH at 37°C for 45 minutes. All 
experiments performed with APMA must follow the guidelines established for using 
organic mercuric compounds, including wearing appropriate protective equipment. The 
initial activation rate of the probes was measured by incubating 10 µM peptide probe with 
569 nM (0.2 ng/µL) activated MMP-2 in distilled water or in PBS at 37°C for 3 hours. We 
monitored the reaction by recording the absorbance at 613 nm (λmax, dimer), 668 nm (λmax, 
monomer), and 630 nm (isosbestic point) over time. Absorbances were normalized by the total 
concentration calculated at the isosbestic point to account for a drift in concentration over 
time due to evaporation. The initial rate of activation was calculated by fitting a linear 
regression model between the 6th and 15th minute, a range over which thermal stabilization 
was achieved. Measurements were performed three times with 2-3 replicates each time. 
3.2.6   Photoacoustic signal acquisition 
The photoacoustic experimental setup used to measure transient photoacoustic 
absorption was described in detail previously and reproduced in Figure 3.2(a). [114] A 
pump-probe system comprising two Q-Switched Nd:YAG lasers (Phocus Mobile, Opotek, 
and Quantel, Brilliant), each equipped with a second harmonic generator, delivered 5 
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nanosecond pulses at 10 Hz repetition frequency. Each beam was directed into an optical 
parametric oscillator (OPO; MagicPRISM, Opotek) for wavelength conversion. The pump 
and probe wavelengths were tuned near the maximum of absorption of MB monomers (660 
nm) and the maximum of absorption of the transient excited state (830 nm) to maximize 
signal generation. The beams were then combined into a bifurcated randomized fiber 
bundle to ensure a uniform illumination of a plastic tube containing the samples. The output 
of the light guide was inserted into a 3D-printed photoacoustic chamber and aligned with 
the tube and a focused ultrasound transducer (f = 25 mm, Panametrics, V311, 10 MHz) 
(Figure 3.2(b)). The optical energies after the light guide were 12 and 17 mJ for the pump 
and probe laser, respectively. A peristaltic pump (Dolomite Microfluidics, MA) was used 
to draw the solutions in alignment with the light guide and the transducer. Laser firing, 
ultrasound acquisition, and the delay between the two pulses were controlled by MATLAB 
via a field-programmable gate array (FPGA, KNJN, FX2 Saxo). Pump-probe delay times 
were randomized to correct for time-dependent photobleaching of the solutions. The 
photoacoustic signal was recorded by a digital oscilloscope (Lecroy, LC584) and processed 
with MATLAB. Noise reduction was achieved by averaging the signal over 100 
measurements during acquisition.  
3.2.7   Photoacoustic signal processing 
 For each pump-probe delay time, the transient photoacoustic signal was obtained 
by subtracting the signal recorded with the pump laser only and the probe laser only from 
the signal recorded with both lasers: tPA = PA660+830 − PA660 – PA830. The signals were 
then processed with a Wiener filter followed by an averaging filter. The envelope was 
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detected using the Hilbert transform method. Finally, the photoacoustic lifetime was 
evaluated by exponential fitting of the transient photoacoustic signal at the dye-plastic wall 
interfaces in function of pump-probe delay time. 
3.2.8   Oxygen partial pressure measurements 
The oxygen partial pressure was measured in a small volume (50 µL) of solution 
contained in a microcentrifuge tube using a retractable fiber-optic oxygen probe needle 
(OXR50, Pyroscience) and an optical oxygen meter (Firesting O2, Pyroscience). The 
measurements were averaged over 150 seconds after signal stabilization was reached. 
3.2.9   Statistical analysis  
An unpaired two-sampled t-test was used for statistical analysis of the probe 
activation data. The data were expressed as means ± standard error (SEM) from 3 repeat 
activation experiments using 2-3 replicates. Each repeat experiment was conducted with 
freshly activated MMP-2.  
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Figure 3.2. (a) Photoacoustic experimental setup. A 3D printed chamber ensures a repeatable and precise 
alignment between the light guide, the plastic tube filled with the sample, and the ultrasound transducer. (b) 
Photoacoustic chamber during laser firing.  
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3.3 RESULTS AND DISCUSSION 
3.3.1 Quenching of MB2K conjugate is driven by MB dimerization 
We first tested the hypothesis that intramolecular connection of two MB molecules 
by a short indirect covalent link results in stable dimerization and quenching. A single 
lysine was chosen as the linker, and it was verified that the amino acid absorbs negligibly 
in the wavelength range of this experiment (data not shown). Absorbance spectra were 
collected for free MB, singly conjugated control MBK, dually conjugated MB2K and 
hydrolyzed MB-NHS ester (MB-COOH) at different dilutions. Increasing the 
concentration of free MB dye results in a hypsochromic shift of the maximum of absorption 
from 665 nm to 608 nm as seen in sandwich-type (H-type) dimers (Figure 3.3(a)) [123]. 
By contrast, MB2K displays a spectral shape that is invariant with concentration with an 
absorption peak at 608 nm (Figure 3.3(b)), suggesting that a single unimolecular dimer 
dominates the solution. To further demonstrate that this peak is caused by intramolecular 
MB pair interaction and not by intramolecular MB-lysine interaction, we measured the 
spectrum of the singly conjugated control MBK, which revealed that MBK undergoes 
aggregation/dissociation processes marked by a peak shift similar to that of free MB 
(Figure 3.3(c)). These combined results suggest that a pair of MB molecules held in close 
proximity by a covalent linker form a stable dimer in aqueous solution. Finally, MB-COOH 
dimerizes like free MB and MBK in solution (Figure 3.3(d)).  
Interestingly, the absorption spectrum of MB2K does not match the MB dimer 
spectrum calculated from the dimerization model used in our previous study, and exhibits 
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both a lower peak at 608 nm and a higher peak at 665 nm. [114] Characterization of MB2K 
solution by mass spectrometry revealed that the solution contained 3% MBC-OOH, which 
corresponds to a MB-COOH concentration ranging from 0.80 to 3.71 µM across the 
dilutions – a range at which monomers represent more than 97% of all species. This would 
translate into a spectral decline of up to 946 M-1.cm-1 at 608 nm and a spectral rise of up to 
2,060 M-1.cm-1 at 665 nm, which can only partially explain the extent of the observed 
deviation. An alternative explanation is that a portion (26% according to our model) of 
dually-conjugated MB2K remain undimerized, resulting in a higher absorption in the 
monomer region. Finally, it is possible that MB2K conjugates are completely dimerized 
but that their spectrum is different from that of pure MB dimer. 
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Figure 3.3. Extinction coefficient spectra of free MB dye (a), dually conjugated MB2K (b), singly conjugated 
MBK (c), and MBCOOH (d) diluted at different concentrations in PBS. Dashed lines represent the pure MB.  
We assessed the quenching of MBK and MB2K by measuring their photoacoustic 
lifetime signal. Figure 3.4(a) shows the transient photoacoustic signal of the two conjugates 
for increasing pump-probe delay times (0.25, 1 and 2 µs). The back and front dye/plastic 
interfaces are visible at x = 0.9 mm and x = 2.6 mm, respectively. The photoacoustic 
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lifetime was obtained by fitting an exponential to the maximum of the PA signal in function 
of pump-probe delay time (Figure 3.4(b-c)). One can see that both conjugates present a 
photoacoustic lifetime, however the amplitude of the exponential fit decreases by 30-fold 
between MBK and MB2K. The lifetimes were estimated to be 1.4 ± 0.2 µs (R2 = 0.98 ± 
0.02) for MBK and 1.0 ± 0.6 µs (R2 = 0.81 ± 0.13) for MB2K. The small signal observed 
for MB2K may be due to the presence of a small amount of monomeric species, either in 
the form of MB-COOH monomers or undimerized MB2K, however the lower R2 values 
and higher standard deviation suggest that it could be the result of curve fitting error 
stemming from low signal-to-noise ratio (SNR). In conclusion, the decrease in lifetime 
amplitude for MB2K combined with a similar photoacoustic lifetime for the two conjugates 
demonstrates that MB2K is statically quenched. 
 
 
Figure 3.4. (a) Transient photoacoustic signal of a plastic tube filled with MBK (blue) and MB2K (red) at 50 
µM in 1X PBS at three different pump-probe delay times (0.25 µs, 1 µs and 2 µs). (b-c) Photoacoustic lifetime 
signal of MBK (▽) and MB2K (○) solutions at the front (x = 0.9 mm) and back (x = 2.6 mm) dye-plastic 
interfaces. The lifetimes were calculated by applying an exponential fit to the maximum of the signal. 
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We previously stated the hypothesis that MB dimers have a short excited-state 
lifetime of a few tens of nanoseconds.  However, our results do not show that MB2K 
conjugates have a short lifetime component in this time range. This observation was 
verified by measuring the transient absorption of MB2K with an excitation wavelength at 
the isosbestic point (625 nm) using flash-photolysis (data not shown). This suggests that 
MB2K may not undergo intersystem crossing to a triplet state but another type of de-
excitation process such as direct relaxation from the singlet to the ground state. 
3.3.2 Photoacoustic activatable probe design 
We compared the basic functionality of 12 activatable peptide probes with general 
structure MB-Kz(e)n[Ahx]PLGLAG(r)mzK-MB, as well as a pre-activated and non-
activatable controls (Table 3.1). We studied the effect of varying the length of the 
electrostatic zipper ((e)n(r)m) and introducing a flexible linker (z) on 
dimerization/separation efficiency and activation rate to identify the optimal probe 
sequence. Finally, we measured the lifetime contrast before and after incubation with 
MMP-2 to determine the photoacoustic quenching efficiency of the activatable probes. 
3.3.3 Validation of E4R5 activation  
The E4R5 probe was activated by MMP-2 over the course of 2.5 hours (Figure 
3.5(a)). The absorption peak shifts from a state consistent with dimerization to a state 
consistent with monomerization, indicating cleavage. The maximum of absorption of the 
uncleaved and cleaved form of the probes were red-shifted by about 4 nm compared to free 
MB dye. The activation was monitored at 613 and 668 nm (Figure 3.5(b)). 
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Probe n (e-) m (r+) z Targeting sequence 
E4 4 - - PLG 
R5 - 5 - LAG 
E0R0 0 0 - PLGLAG 
E0R1 0 1 - PLGLAG 
E1R2 1 2 - PLGLAG 
E2R3 2 3 - PLGLAG 
E3R4 3 4 - PLGLAG 
E4R4 4 4 - PLGLAG 
E4R5 4 5 - PLGLAG 
E5R6 5 6 - PLGLAG 
E4DR5 4 5 - plglag 
E4scrR5 4 5 - Pgallg 
GE4R5G 4 5 G PLGLAG 
XE3R4X 3 4 [Ahx] PLGLAG 
XE4R5X 4 5 [Ahx] PLGLAG 
XE5R6X 5 6 [Ahx] PLGLAG 
 
Table 3.1. Designs of the activatable probe sequences of the general form MB-Kz(e)n[Ahx]PLGLAG(r)mzK-
MB, where n represents the number of D-amino glutamic acids, m represents the number of D-amino 
arginines, and z represents a flexible linker (G, 6-aminohexanoic acid [Ahx], or none). A simplified naming 
convention (zEnRmz) is used to describe the different probe designs. Pre-activated positive controls are 
identified as E4 and R5. Negative D-amino and scrambled controls are identified as E4DR5 and E4scrR5, 
respectively. 
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Figure 3.5. (a) Absorption spectra of E4R5 probe (10 µM) before and after incubation with MMP-2 (0.2 
ng/µL) for three hours. (b) Absorption change throughout incubation measured at 613 and 668 nm. 
3.3.4 Comparison of activatable peptide probes to optimize imaging contrast 
In order to enlighten the structure/function relationship and identify the optimal 
probe, we compared the dimerization state and quenching efficiency of the different probes 
before and after incubation with MMP-2.  
Before MMP-2 treatment, dually conjugated probes consistently showed a 
dominant absorption peak in the dimer region (data not shown) though dimerization 
efficiencies vary amongst designs (Figure 3.6). E3R4, E4R5 and E5R6 probes displayed a 
higher dimer-to-monomer ratio (D:M) than their counterparts with a G or a X linker (P < 
0.0001 for each comparison). Furthermore, the D:M decreased significantly with linker 
size when comparing probes of the same zipper length (D:ME4R5 > D:MGE4R5G > 
D:MXE4R5X) (P = 0.00006 for both comparisons). These results indicate a size-dependent 
disruption of MB dimerization by flexible linkers, which we posit may be mediated either 
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by increased conformational freedom or by increased distance between the chromophores. 
Additionally, whereas the D:M did not differ significantly between E0R1, E2R3, E3R4, 
E4R5 and E5R6 probes, the D:M of XEnRmX probes was inversely related to their length 
(r = 0.998, P = 0.04). This suggests that flexible linkers may counteract the electrostatic 
attraction of the zipper. On the other end, the zipper-free E0R0 probe displayed a 10% 
lower D:M than other EnRm probes apart from E1R2 (P < 0.001 for each comparison),  
highlighting the role of the zipper in facilitating MB dimerization through electrostatic 
attraction of the two halves of the probe, increased conformational flexibility, or both. 
Finally, the D:M of E4R5 probe and its non-activatable D-amino and scrambled controls 
E4DR5 and E4scrR5 were not found to be significantly different (P > 0.001), which 
indicates some level of latitude in modification of the recognition sequence without 
impacting dimerization. 
Incubation of EnRm probes with MMP-2 led to an 80 % average decrease in D:M 
with a final D:M comparable to that of split controls E4 + R5, indicating a complete 
separation of MB chromophores. In comparison, the non-activatable controls E4DR5 and 
E4scrR5 exhibit greatly reduced change in D:M (approximately 10 %), which supports the 
notion that the PLGLAG recognition sequence enables MMP-2 cleavage. The small change 
may indicate that cleavage took place to a lower extent over the incubation period, possibly 
due to enzymatic action or to reaction conditions. GE4R5G and XEnRmX probes showed 
a higher D:R than EnRm probes (except E5R6) after MMP-2 treatment (P < 0.001). We 
posit that the presence of a linker may partially hamper the separation of the probes or that 
the linker impacts MB’s absorption spectrum. 
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Figure 3.6. Mean (± SEM) of the dimer-to-monomer absorption ratio (D:M) of the peptide probes (10 µM) 
before and after incubation with MMP-2 (0.2 ng/µL) for three hours. 
 
Two cleavable probes (E2R3 and E4R5) as well as the split and scrambled controls 
were assessed for their quenching efficiency (Figure 3.7). After MMP-2 treatment, the 
photoacoustic lifetime amplitude increased by 6- and 260-fold for E4R5 and E2R3, 
respectively (Figure 3.7(a-b)), although it was slightly higher for E4R5 than for E2R3 
before incubation. This may be partially explained by the presence of a small amount of 
pre-cleaved E4R5 before adding the enzyme, which is supported by a greater monomer 
absorption peak for E4R5 (data not shown). In addition, the difference may be explained 
by the uncertainty associated with the exponential fit before incubation due to low SNR, 
which translates into the low R2 presented below. The scrambled control retained a low 
photoacoustic lifetime signal before and after enzymatic incubation (Figure 7d), whereas 
that of the split control remained high, although with an 18% decrease after incubation 
(Figure 3.7(c)).  
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Interestingly, the lifetime of the split controls was found to be reduced by half (from 
1.56 µs to 0.76 µs) after incubation. We tested the hypothesis that this difference may be 
caused by an increase in collisional quenching between MB molecules and oxygen by 
measuring the oxygen partial pressure (pO2) in E4 + R5 before and after incubation (Table 
3.2). pO2 was slightly lower after incubation, which would translate into an increase in 
photoacoustic lifetime. However, the measured lifetime was lower after incubation, which 
contradicts our hypothesis. We also tested the influence of TCNB incubation buffer and 
NaOH on the photoacoustic lifetime of E4 + R5 (Figure 3.8), but did not observe a change 
comparable to the one seen after enzymatic incubation. From these results, we posit that 
the lifetime difference before/after activation may be due to heating during the incubation 
process or to the presence of APMA or MMP-2. 
 
 
Table 3.2. Oxygen partial pressure measured in E4 + R5 solutions (50 µM) before and after activation 
incubation with MMP-2 (2 ng/µL) for one hour. We tested the hypothesis that this difference may be caused 
by an increase in collisional quenching between MB molecules and oxygen by measuring the oxygen partial 
pressure (pO2) in E4 + R5 before and after incubation. pO2 was slightly lower after incubation (107 mmHg 
vs 120 mmHg), which would translate into an increase in photoacoustic lifetime. However, the measured 
lifetime was lower after incubation, which contradicts our hypothesis. 
 
 
Probe pO2 τ (µs) – (R2) 
Before incubation 120 mmHg 2.5 (0.918) 
After incubation 107 mmHg 0.87 (0.903) 
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Figure 3.7. Photoacoustic lifetime signal of the back of a plastic tube filled with E2R3 (a), E4R5 (b), E4 + 
R5 (c) and E4scrR5 (d) solutions at 50 µM before (○) and after (▽) incubation with MMP-2 (2 ng/µL) for 
one hour. The lifetimes were calculated by applying an exponential fit to the maximum of the envelope signal. 
Dashed lines represent fits with R2 < 0.5. 
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Figure 3.8. Photoacoustic lifetime signal of E4 + R5 solution (50 µM) in 1X PBS buffer (○), PBS + TCNB 
+ NaOH (▽), PBS + TCNB (□), and PBS + NaOH (◇). The different solutions were mixed according to 
their relative volume fractions in the activation buffer. The addition of TCNB and NaOH separately or 
simultaneously did not result in a decrease in photoacoustic lifetime as observed after enzymatic incubation. 
In vivo imaging of enzyme activity using an activatable probe requires high contrast 
differentiation between the inactive and active state of the probe. The preceding results 
indicate that this condition is best satisfied by a probe with MB directly conjugated to the 
terminal lysines (i.e. without a flexible linker) due to their high dimerization and self-
quenching efficiency before cleavage, and high separation efficiency and photoacoustic 
lifetime signal after cleavage. Probes with an electrostatic zipper exhibited superior D:M 
ratio than the zipperless design, but extended length of the electrostatic zipper was not 
found to significantly impact dimerization and separation efficiency. Notably, after 
cleavage, one of the monomers contains a polyarginine segment, which could enable cell 
penetration and accumulation of half the probe in cells expressing or proximal to MMP-2 
[16]. 
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3.3.5 Comparison of activation rate between peptide probes 
In order to more finely investigate the influence of probe structure on its 
attachment/separation after cleavage, we compared the initial activation rate of the probes 
incubated with MMP-2 and in distilled water.  
The initial rate of activation (V0) was 20 to 33 times higher in activatable probes 
incubated with the enzyme than in those incubated in distilled water (Figure 3.9). In 
addition, no significant difference was found between activatable probes and the negative 
controls in the absence of MMP-2 (P > 0.1). These results suggest that most of the cleavage 
is due to enzymatic activity and not to spontaneous separation of the MB moieties or non-
specific proteolytic cleavage. Moreover, the initial rates for E4DR5 and E4scrR5 controls 
were essentially the same with and without enzyme (P > 0.1), indicating that the D:R 
change observed for these controls is likely due to incubation conditions and not to 
enzymatic action. 
 
Figure 3.9. Mean (± SEM) of the nitial rate of activation of the peptide probes (10 µM) incubated with and 
without MMP-2 (0.2 ng/µL) for three hours. 
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Apart from E0R0, the activation rate of linkerless probes – but not that of XEmRnX 
probes – was found to decrease with peptide length when incubated with MMP-2. This 
dependence may be explained by an increase in binding affinity of the zipper side chains 
with length that would delay their separation after probe cleavage, or by side chain impact 
on the local conformation and accessibility of the cleavage site. The lower rate calculated 
for E0R0 may be due to a modified conformation of the cleavage site in the absence of a 
substantial linker between MB dimer and the protease recognition sequence. Additionally, 
V0 decreased with linker size when comparing probes of the same length (V0,E4R5 > 
V0,GE4R5G > V0,XE4R5X), however we did not find the difference between probes to be 
statistically significant (P > 0.05). 
In vitro testing of a smart probe’s activation rate does not directly translate into in 
vivo probe behavior due to the complexity of live biological processes, but choosing a 
probe with an adequate activation rate and low non-specific activation provides some 
advantages. Because MMP enzymes can sometimes be found in the bloodstream [124], 
some level of activation in the blood and accumulation into tissue or clearance organs may 
occur, which could lead to off-tumor signal. Another level of complexity comes with probe 
specificity towards different enzymes, particularly those from the MMP family, which 
presents similar three-dimensional structures and substrate specificity [125]. One study 
comparing the sensitivity of the PLGLAG sequence to different enzymes found it to be 
mostly cleaved by MMP-2 and -9, and, to a lesser extent, by MMP-14 [115]. Since different 
tumor sites secrete different enzymes at different stages of cancer progression [27], the 
tumor enzymatic profile must be carefully considered when imaging an enzyme-specific 
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probe in vivo. For example, the expression and activity of MMP-2 secreted by prostate 
cancer tumors is not the same at the early and advanced stage, and higher plasma MMP-2 
activity levels were correlated with invasive and metastatic behavior [126]. This property 
may be exploited for cancer diagnosis and/or prognosis, by tailoring an activatable probe 
to an enzyme whose activity is upregulated during a specific stage of cancer progression. 
3.4 CONCLUSION 
We have demonstrated the design and in vitro characterization of the first 
activatable photoacoustic lifetime probe. We have showed that a pair of MB chromophores 
linked via an enzyme-cleavable polypeptide dimerize and that their photoacoustic lifetime 
signal is suppressed due to self-quenching. The MMP-2 driven cleavage of the covalent 
linkage indirectly connecting the MB moieties results in probe separation and detection of 
microsecond photoacoustic lifetime signal. We have determined that probes without a 
flexible linker dimerize better before activation, which may translate into lower non-target 
signal in vivo, and less after cleavage, which would allow for a greater contrast. Finally, 
we have showed that the initial activation rate is decreasing with peptide length in 
linkerless probes. Other validation criteria for the probe may be tested in the future, such 
as cellular uptake, enzyme specificity, stability in the blood and toxicity to the cells. 
Moreover, the probe design can be adapted for testing a variety of biological and disease 
molecular markers, both enzyme and DNA-based, by changing its recognition site 
sequence. Potential applications in the field of molecular imaging include enzyme-targeted 
drug research, cancer and inflammation-related disease diagnosis, and planning and 
monitoring of treatment efficacy. 
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Chapter 4. Towards in vivo imaging 
Development of a multimodal US/PA/PALI imaging system 
 
4.1   INTRODUCTION 
A new multimodal imaging system (US/PA/PALI) is under development at the 
Photoacoustics and Ultrasound lab at the University of Minnesota. The end goal is to 
integrate a dual-wavelength pulsed laser system, a bifurcated optical fiber for light 
delivery, and an ultrasound imaging probe into a portable imaging system for clinical use. 
A computer was programmed for data acquisition, reconstruction and real-time display of 
PALI functional information co-registered with anatomical ultrasound images. This 
chapter introduces the current imaging setup and the image formation process based on 
event-driven programming using MATLAB – including acquisition, reconstruction and 
processing steps. We demonstrate the capability of our system by imaging a plastic tube 
filled with MB solution and show a good overlay between the PA and US signal. Then we 
describe a preliminary experiment conducted on a euthanized mouse whose hindlimb was 
injected with MB dye and imaged by our system. Lastly, we present several improvement 
ideas for the imaging setup and discuss the challenges in implementing this technique in 
living subjects. Application of this imaging system with the photoacoustic activatable 
probe described in Chapter 3 would yield a map of target enzyme activity and oxygen 
partial pressure in tissue. This could be used by physicians to monitor the effect of a 
treatment on oxygen and enzymatic biomarkers and establish clinical endpoints. 
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4.2   METHODS 
 4.2.1   Imaging setup 
The multimodal imaging system is composed of a research ultrasound (US) system 
(Vantage 64, Verasonics), two tunable pulsed laser systems (Phocus Mobile, OPOTEK), a 
Windows computer, and a FPGA-based synchronization box (Figure 4.1). The US system 
is connected to a 64-channel phased array transducer (P7-4, ATL) with 5 MHz center 
frequency and 3 MHz bandwidth. The transducer functions as a transmitter-receiver in 
pulse-echo US imaging mode and as a receiver only in PA/PALI imaging. The Verasonics 
clock output (15.625 MHz) is used as the common synchronization signal for laser firing 
and signal acquisition. The exact timing between pump and probe pulses and the start of 
the acquisition is programmed into the FPGA contained in the synchronization box 
(EP3C5, ALTERA Cyclone III series). The output laser beams are homogenized in a 
bifurcated fiber bundle and delivered to the imaging target as a slowly diverging beam (ø 
5.45 mm - NA = 0.22). Independent wavelength tuning is performed by an optical 
parametric oscillator (OPOTEK) within the laser system enclosure. The US transducer and 
the fiber bundle are first manually aligned with the imaging target, then the position of the 
transducer is adjusted so that the field of view is centered on the target by observing real-
time US images displayed on the computer.  
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Figure 4.1. Multimodal imaging system setup. The Verasonics imaging system sets the clock (15.625 MHz) 
of the synchronization box which sets the time delay between the pump and probe pulses and triggers laser 
firing and ultrasound acquisition. The two lasers can be fired either by the computer (continuous mode) or 
the synchronization box (burst mode). A phased-array transducer records US and PA measurements. The 
data is then amplified, digitized, eventually displayed, and stored in the Verasonics system. Finally, the data 
can be transferred to the computer for image reconstruction and processing. 
 
  4.2.2 Image acquisition 
  Image acquisition can be programmed by writing a MATLAB script containing a 
sequence of actions, referred to as events, in both the hardware and software environment. 
There are four types of events: Transmit, Receive, Reconstruct, Process and Control. A 
script also generates a collection of objects, in the form of structures, which specify a set 
of attributes used during the sequence of events. A typical example is the transducer object, 
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with structure ‘Trans’, and attributes ‘name’, ‘frequency’ and ‘type’. When the setup script 
executes, the sequence of events loads into both the hardware and software sequencers and 
the acquisition starts. Asynchronous programming between hardware and software events 
was implemented to optimize the acquisition speed and the frame rate for real-time display. 
  A US imaging script starts by specifying the transmit (e.g. waveform and beam 
characteristics) and receive (e.g. time gain compensation and apodization) objects. For PA 
imaging, the transmit object can be left unfilled or the transmit apodization set to zero. In 
all subsequent imaging experiments, US images were acquired by the synthetic transmit 
aperture (STA) technique [127, 128]. This technique provides full dynamic focusing both 
in transmit and receive modes, yielding high-resolution images. At each step, a single 
element transmits an ultrasound pulse and the echo signal is recorded by all the receiving 
elements. The step is repeated for each of the 64 transmit channels. PA images were 
acquired by receiving on all elements simultaneously following laser firing. The signal was 
averaged 100 times for both US and PA imaging and the RF data was saved into local 
memory. US acquisition lasted less than a second and the full PALI acquisition for a set of 
9 pump-probe time delays took about 3 minutes.  
  The main attributes within the setup script that can be used to optimize image 
acquisition are represented in blue during the acquisition step in Figure 4.2. Those are the 
TGC amplification waveform, the anti-aliasing filter, the low pass filter, and the decimation 
rate. The transmit and receive structures can also be modified to evaluate different 
beamforming techniques.  
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Figure 4.2. Schematics of the image formation process.  DAC: Digital-to-analog. ADC: Analog-to-digital. 
4.2.3 Image Reconstruction and Processing 
The execution script can reconstruct an image in real-time using a delay and sum 
algorithm and display it on the computer screen through a graphical user interface (GUI). 
The user can specify the sensitivity cutoff in one of the reconstruction objects and set the 
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gain and the compression level during processing. However, for better control of the 
reconstruction parameters and to perform coherent subtraction of PA images for PALI 
reconstruction, we chose to apply our own reconstruction algorithms (Figure 4.2). 
At the end of an acquisition event, the RF data is transferred to the computer and 
stored in a receive buffer. For each receiving element, an amplitude image was 
reconstructed by the delay-and-sum method (two-way for US, one-way for PA). These 
images were then summed up coherently and their envelope was detected by the Hilbert 
transform method along the axial direction. To obtain PALI images, each pixel of a series 
of PA images acquired for different pump-probe time delays was fit to an exponential, and 
pixels with a goodness of fit parameter R2 lower than a set threshold (typically 0.9) were 
rejected. Finally, an averaging filter was applied to filter out high frequencies and a 
morphological opening operation was performed to remove isolated pixels to improve 
visualization. Finally, US and PALI information was co-registered and displayed on the 
same image with different colormaps. 
4.2.4 Phantom experiment 
  Methylene blue (MB) hydrate (purity ≥ 97%) solution was dissolved to 100 µM 
and flown through a plastic tube placed in front of the fiber bundle inside a water tank. The 
fiber bundle and US tranducer positions were adjusted so that the fiber bundle illuminated 
the tube homogeneously and the tube was in the center of the transducer’s field of view 
approximately 1 cm from its surface. 
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4.2.5 Animal preparation 
White mice were euthanized by CO2 inhalation at the Research Animal Ressources 
(RAR) at the University of Minnesota and immediately brought to the PUL laboratory. The 
area of the hindlimb was shaved and injected with MB (2mM – 0.5 mL) dissolved in 
physiological saline (PBS 1X, Mediatech) intramuscularly. The mice were then affixed to 
an imaging platform placed in a water tank, and the US transducer and the fiber bundle 
were aligned with the stained area with an 80° angle between them (Figure 4.3). 
 
Figure 4.3. Example of an imaging platform for small animal imaging. The mouse used in this experiment 
has been euthanized prior to MB injection to the hindlimb and transfer to the imaging setup.  The mouse was 
fixed to a small optical breadboard and submerged in water (in a live experiment the head of the mouse would 
be above water level). The stained area is illuminated by a randomized lightguide with a small ziploc bag at 
the tip to protect it from water. The phased-array transducer was positioned above the stained area and aligned 
with the illumination spot using a MATLAB script displaying the PA image in real time. 
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  4.3 RESULTS 
4.3.1 Phantom imaging 
 In order to demonstrate the capability of multimodal imaging, we imaged a plastic 
tube filled with MB solution. The US image was displayed in dB scale (Figure 4.3(a)), and 
the PA images with only the pump laser (660 nm, Figure 4.3(b)) and only the probe laser 
(830 nm, Figure 4.3(c)) in colorscale. The two PA signals represent the location of the 
plastic wall-solution interface, and overlap nicely with the US image. The PA signal at 660 
nm corresponds to the absorption of MB monomers, whereas the PA signal at 830 nm 
arises from the plastic tube itself. Figure 4.3(d) shows the transient PA image which is the 
amplitude of the exponential fit over a series of PA images obtained with increasing pump-
probe delay times and with both lasers on. Although the transient PA signal is smaller than 
even the PA signal at 830 nm, PALI imaging is able to detect it efficiently and to correctly 
reflect the structure of the tube. 
4.3.2 Animal imaging 
 We conducted a preliminary experiment to show the application of multimodal 
imaging to a volume of tissue by imaging a euthanized mouse’s hindlimb stained with MB. 
The US image shows the outline of the hindlimb of the mouse and the tip of the fiber bundle 
in contact with the surface of the skin (Figure 4.5(a)). This close configuration was initially 
chosen to maximize light delivery. The PA images obtained with pump and probe laser 
only show a penetration depth of 6-7 mm, however there is strong PA signal coming from 
outside the tissue at the location of the fiber bundle and below it (Figure 4.5(b-c)). The 
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transient PA image obtained from the exponential fit shows both a sparse and low intensity 
signal inside the tissue and a high intensity signal at the location of the fiber bundle and in 
the first 2 mm of tissue (Figure 4.5(d)). Furthermore, the goodness of fit was not very good 
leading us to choose a low R2 threshold of 0.7. Overall, the region of tissue where we can 
confidently identify transient absorption is limited and the penetration depth is poor.  
 
Figure 4.4. Multimodal imaging of a tube filled with MB (100 µM). (a) US image in dB scale. Dashed line 
shows the position of the tube. (b) PA image at 660 nm. This corresponds to the spatial absorption of light 
by MB molecules. (c) PA image at 830 nm. This corresponds to the background absorption by the plastic 
tube. (d) Transient PALI amplitude calculated from the exponential fit. Data points shown for R2 > 0.9.  
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Finally, the oxygen partial pressure (pO2) image was calculated by converting the 
photoacoustic lifetime (Figure 4.5(e)) into pO2 using the Stern-Volmer relationship 
introduced in Chapter 1 (Figure 4.5(f)). The pixels in the first 1-2 mm from the surface 
showed a pO2 in the 40-180 mmHg range, near the pO2 value in air at approximately 160 
mmHg [129]. From about 4 to 7 mm from the surface, the pO2 was in the 5-120 mmHg 
range. pO2 level in the femoral muscle of a live mouse was found to be 10.6 ± 1.8 mmHg 
at 25°C and 29.1 ± 7.8 mmHg at 37°C [130]. Then again, the low R2 value throughout the 
pixels introduces a level of uncertainty in the pO2 results, which makes the above results 
inconclusive. 
Figure 4.5. Multimodal imaging of a euthanized mouse. (a) US image of the hindlimb of a mouse in dB 
scale. Yellow dashed line represents the hindlimb. Blue dashed line shows the lightguide. (b)  PA image at 
660 nm shows the penetration depth of the pump laser pulse. (c)  Background PA tissue absorption at 830 
nm. (d)  Transient PALI amplitude calculated from the exponential fit. Data points shown for R2 > 0.7. (e)  PA 
lifetime in µs. (f) Oxygen partial pressure (pO2) in mmHg.  
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The low and heterogeneous transient photoacoustic signal may be attributed to 
different causes:  
1. The shadowing of acoustic energy by the fiber bundle. In this experiment the 
fiber bundle was placed close to the skin surface at an 80° angle with the US transducer. 
In retrospect, this configuration may have caused ultrasonic reflection at the surface of the 
fiber bundle instead of propagation towards the US transducer. In addition, the fiber bundle 
generated some artifacts causing signals to appear outside the tissue, which complicates 
the identification of photoacoustic lifetime signal arising from MB transient absorption. 
2. Low laser energy. At around the time of the experiment we had been dealing 
with a progressive loss in pump energy at the fiber output from 20-22 mJ to 12-13 mJ over 
the course of several weeks. Lower laser energy translates into lower power density 
resulting into less pump energy being absorbed by MB molecules, which can ultimately 
impact the photoacoustic lifetime signal amplitude.   
3. MB aggregation and lifetime quenching. Considering a stained volume of tissue 
with dimensions 15x15x15 mm, the MB concentration inside the stained tissue was 2.96 x 
10-4 M, which is comparable to the dissociation constant calculated in Chapter 2. The 
implication is that approximately half of the MB molecules would be dimerized at the same 
concentration in solution. In addition, MB is a cationic dye that can bind to the plasma 
membrane [131], which can result in local aggregation of MB molecules at high 
concentrations. We posit that at least a fraction of MB molecules are present as dimers 
within the stained tissue, and that this fraction does not contribute to photoacoustic lifetime 
signal generation due to static quenching. 	
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4.4 PROPOSED IMPROVEMENTS AND REMAINING CHALLENGES 
In future experiments, we recommend that the distance and the angle between the 
fiber bundle and the US transducer be investigated to yield the maximum of light delivery 
and acoustic propagation without obstructing the field of view. This can be accomplished 
by creating an adjustable holder that binds fiber and transducer together and could also 
ensure a repeatable positioning of these two elements across different experiments (Figure 
4.6). 3d printing can be used to design and produce a prototype for this holder. In the design 
described in this section, the current circular fiber bundle has been replaced by a fiber 
bundle bifurcated on both sides with two rectangular output terminals (Figure 4.6(a)). The 
individual fibers in the input section are randomized in the middle section and then split to 
deliver a homogenized beam containing both pump and probe beams. This allows for a 
more uniform and symmetrical illumination of the target object or tissue. Because the fibers 
are split between the two terminals, the output energy is also divided by half in both 
bundles. Therefore, the maximum of laser energy deposition occurs where the output 
beams overlap (Figure 4.6(b)). Alternatively, a focusing length system at the tip of the fiber 
terminals may be employed to limit the spread of the output beams. The holder prototype 
can be designed to allow for rotational and translational degrees of freedom to optimize the 
distance and the angle between the US transducer and the fiber bundle. Once an optimal 
position has been found, the configuration of the holder may be locked in place or a new 
holder may be manufactured with the chosen specifications. 
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Figure 4.6. (a) Proposed design of the holder for the US transducer and fiber bundle. (b) Translational 
movement of the transducer and rotational movement of the fiber bundle outputs enable optimization of the 
distance and angle between the two.  
 Another area of improvement concerns laser energy normalization. Pulse-by-pulse 
energy variations can be effectively eliminated by performing signal averaging for each 
acquisition of a pump-probe delayed signal. However, slow energy drifts exist that can 
translate into fluence variations between acquisitions. Each laser system can be 
supplemented with a power/energy meter (Pulsar, Ophir Optronics) that can measure 
individual pulse energy. When running a MATLAB script, the pulse-by-pulse energy can 
be recorded in real-time, averaged for each pump-probe delay time, and the RF data can be 
corrected for energy variations between acquisitions. Furthermore, continuous monitoring 
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of laser energy may inform users if the energy decreases dramatically and if 
troubleshooting is necessary. 
 Another challenge in PALI imaging is that the excited-state lifetime of MB in in 
vivo settings can be influenced by other factors than oxygen level, such as temperature, pH, 
and even aggregation on biological structures such as the cell membrane. Another complex 
factor is depth. Indeed, the PA signal p0 generated at any given point in space is a function 
of the local optical fluence Φ, which is the local optical energy per unit area [41]: 
p" = 	Γ	×	µ5×	ϕ 
where Γ is the Grüneisen parameter (a thermodynamic property of tissues) and µa is the 
local optical absorption coefficient. If the fluence was uniform throughout the imaged 
volume of tissue, then the PA signal would be directly proportional to the optical absorption 
coefficient. In practice, however, the light is attenuated as it travels through the tissue. This 
creates a non-linear dependence of the transient photoacoustic signal and observed excited-
state lifetime with depth (Figure 4.6). The effect of pump and probe light attenuation in 
tissue is complex and depends on the concentration and spatial distribution of 
photoabsorbers – both endogenous and dye. However, the potential implications of this 
effect are profound at high imaging depths and would benefit from careful experimental 
investigation to determine the extent of the discrepancy between real and observed lifetime. 
Anatomically-accurate modeling of light propagation in biological tissue using the Monte-
Carlo approach would also allow for a quantitative analysis of this phenomenon and may 
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lead to the development of a depth-dependent correction algorithm for the measured 
transient photoacoustic signal that could potentially increase imaging depth. 
 
Figure 4.7. Illustration of the difference between real and measured excited-state lifetime. Fluence 
attenuation is manifested as decreasing light beam when travelling through layers of stained tissue. When the 
probing pulse is fired shortly after excitation (tpp = 0 µs), the triplet population within the volume is high 
resulting in strong light absorption in the first layers and fast fluence attenuation. Thus, the observed transient 
photoacoustic signal decreases with depth. For a probing pulse fired a longer time after excitation (tpp >> 0 
µs), the triplet pollution has decreased due to relaxation, resulting in less absorption at the surface and slower 
fluence attenuation. The observed transient photoacoustic signal is then higher than for the first measurement. 
Consequently, exponential fitting would result in a higher and higher lifetime at increasing depths, and may 
even flip in regions where the light does not reach when probing close to the excitation. 
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Chapter 5. Summary and future directions 
We have demonstrated that photoacoustic lifetime imaging (PALI) can probe the 
excited-state lifetime contrast between methylene blue (MB) monomers and dimers. MB 
monomers exhibit a long excited-state lifetime (1.8 to 79.5 µs) which decreases by three 
orders of magnitude upon aggregation due to static quenching. The addition of increasing 
concentrations of sodium sulfate, a dimerization-inducing compound, to a MB solution led 
to a linear decrease of the photoacoustic lifetime signal with the monomer concentration. 
Similarly, the addition of 4 mM sodium docecyl sulfate (SDS) – a concentration that 
amplifies MB aggregation and reduces the monomer concentration by more than 20-fold – 
led to a photoacoustic signal decrease of more than 20 dB.   
We have implemented the monomer-dimer contrast mechanism for the 
development of an activatable photoacoustic probe for enzyme activity detection. The 
probe was composed of two MB chromophores conjugated to an electrostatic zipper via a 
flexible amino acid linker, and connected to a MMP-2 specific recognition sequence 
PLGLAG. In its intact state, the probe structure promotes MB dimerization and static 
quenching rendering low PALI signal. Enzymatic cleavage of the probe leads to the 
separation of MB monomers and high PALI signal. A series of activatable probes with 
varying zipper lengths and flexible linkers were assessed to compare their dimerization and 
separation efficiency, activation rate, and photoacoustic lifetime signal strength as 
compared to a positive and a negative control. Dimerization was highest in probes free of 
a flexible linker. A decrease in the initial activation rate was observed for probes with 
longer electrostatic zippers and probes containing a flexible linker. 
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Finally, we have been developing a portable multimodal system combining 
US/PA/PALI imaging for preclinical/clinical use. Image acquisition was programmed 
using an event-driven script in MATLAB. We demonstrated the capability of this system 
to resolve a phantom tubing object filled with MB and presented some preliminary in vivo 
results by imaging MB-stained muscle tissue in a mouse. Several improvements ideas are 
proposed to improve image quality and penetration depth, such as the development of a 
holder combining fiber bundle and ultrasound transducer into one element.  
These combined results demonstrate the potential of using the new multimodal 
imaging system and the activatable photoacoustic probe to selectively detect enzymatic 
activity in a variety of physiological and disease states. The next stage is preclinical testing 
to evaluate the capability of the imaging system to resolve enzyme activity in vivo. Mice 
can be used as a cancer model for this study. Tumors with different MMP-2 expression 
levels will be grown in the hindlimb of a set of mice. Different modes of activatable probe 
administration will be investigated (e.g. tail vein or intratumorally). The mice will then be 
immersed in a temperature-controlled water tank and imaged by the PALI system. Blood 
samples will be withdrawn at regular intervals to determine probe clearance. After mice 
euthanasia, the tumors will be excised and the imaging results compared to tissue analysis 
of enzyme activity (zymography) using statistical analysis.  
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